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Bipolar disorder is a heritable psychiatric disorder, and several of the genes associated with 
bipolar disorder and related psychotic disorders are involved in the development and 
maintenance of white matter in the brain. Patients with bipolar disorder have an increased 
incidence of white matter hyper-intensities, and quantitative brain imaging studies collectively 
indicate subtle decreases in white matter density and integrity in bipolar patients. This suggests 
that genetic vulnerability to psychosis may manifest itself as reduced white matter integrity, and 
that white matter integrity is an endophenotype of bipolar disorder. This thesis comprises a series 
of studies designed to test the role of white matter in genetic risk to bipolar disorder by analysis 
of diffusion tensor imaging (DTI) data in the Bipolar Family Study. Various established analysis 
methods for DTI, including whole-brain voxel-based statistics, tract-based spatial statistics 
(TBSS) and probabilistic neighbourhood tractography, were applied with fractional anisotropy 
(FA) as the outcome measure. Widespread but subtle white matter integrity reductions were 
found in unaffected relatives of patients with bipolar disorder, whilst more localised reductions 
were associated with cyclothymic temperament. Next, the relation of white matter to four of the 
most prominent psychosis candidate genes, NRG1, ErbB4, DISC1 and ZNF804A, was 
investigated. A core haplotype in NRG1, and three of the four key single nucleotide 
polymorphisms (SNPs) within it, showed an association with FA in the anterior thalamic 
radiations and the uncinate fasciculi. For the three SNPs considered in ErbB4, results were 
inconclusive, but this was consistent with the background literature. Most notable however, was 
a clear association of a non-synonymous DISC1 SNP, Ser704Cys, with FA extending over most 
of the white matter in the TBSS and voxel-based analyses. Finally, FA was not associated with a 
genome-wide supported risk SNP in ZNF804A, a finding which could not be attributed to a lack 
of statistical power, and which contradicts a strong, but previously untested hypothesis. Whilst 
the above results need corroboration from independent studies, other studies are needed to 
address the cellular and molecular basis of these findings. Overall, this work provides strong 
support for the role of white matter integrity in genetic vulnerability to bipolar disorder and the 




BD:  bipolar disorder 
HR:  high risk group (in figures and tables) 
HC:   control group (in figures and tables) 
ALIC: anterior limb of internal capsule 
AF:  arcuate fasciculus 
UF:  uncinate fasciculus 
CING: cingulum bundle 
ATR:  anterior thalamic radiations 
CST:  cortico-spinal tract 
MRI:  magnetic resonance imaging 
DTI:  diffusion tensor imaging 
FA:   fractional anisotropy 
SVC:   small-volume correction 
ROI:   region of interest 
FWE: family-wise error 
FDR: false discovery rate 
IQ: intelligence quotient 
FWHM: Full-width at half-maximum 
SNP:  single nucleotide polymorphism 
GWAS: genome-wide association study 
 
NRG1:  neuregulin-1 
ErbB4:  v-erb-a erythroblastic leukemia viral oncogene homolog 4 
DISC1:  disrupted-in-schizophrenia-1 
ZNF804A:  zinc finger protein 804A 
CACNA1C:  voltage-dependent calcium channel L type alpha 1C subunit 
ANK3:  ankyrin 3 
BDNF: brain-derived neurotrophic factor 
SLC6A4: solute carrier family 6 (serotonin transporter) 
DAOA: D-amino acid oxidase activator 
DGKH: diacylglycerol kinase eta 
7 
 
Table of Contents 
 
Chapter 1: Background 
1.1 Introduction 
1.2 Genetics of bipolar disorder 
1.2.1 Heritability 
1.2.2 Linkage and association studies 
1.2.3 Missing genetic variation 
1.3 Endophenotypes 
1.4 White matter pathology in bipolar disorder 
1.4.1 White matter hyper-intensities, histology and structural MRI in bipolar 
disorder 
1.4.2 Diffusion tensor imaging in bipolar disorder 
1.5 White matter as an endophenotype for bipolar disorder 
1.6 White matter in relation to current neuro-cognitive models of psychosis 
1.6.1 Emotion regulation 
1.6.2 Neurodevelopment and plasticity 
1.7 Summary and aims 
 
Chapter 2: Methods 
2.1 Principles of diffusion MRI 
2.1.1 Diffusion MRI 
2.1.2 The diffusion tensor and derived measures 
2.1.3 Validity and anatomical sources of diffusion measures 
2.2 The Bipolar Family Study 
2.2.1 Participants and clinical and neuropsychological assessments 
2.2.2 Scan acquisition and pre-processing 
2.2.3 Genotyping 
2.3 Whole-brain statistics 
2.3.1 Tract-based spatial statistics 
2.3.2 Threshold-free cluster enhancement 
2.4 Tractography 
2.4.1 Streamlines 
2.4.2 Probabilistic neighbourhood tractography 
2.4.3 Tractography applied to the bipolar family study 
 
Chapter 3: White matter integrity in individuals at high genetic risk of bipolar disorder 
3.1 Introduction 
3.2 Materials and methods 
3.2.1 Study sample and data acquisition 




3.2.4 Voxel-based analysis 
3.2.5 Tractography 
3.3 Results 
3.3.1 Group comparison: voxel-wise analysis 
3.3.2 Group comparison: tractography 
3.3.3 Cyclothymic temperament: voxel-wise analysis 
3.3.4 Cyclothymic temperament: tractography 
3.4 Discussion 
3.4.1 White matter and genetic risk for BD 




Chapter 4: White matter integrity in relation to NRG1 and ErbB4 
4.1 Introduction 
4.1.1 Association studies of NRG1 and ErbB4 
4.1.2 Functions of NRG1-ErbB signalling 
4.2 Methods 
4.2.1 Study sample 
4.2.2 Genotyping and haplotype estimation 
4.2.3 TBSS and tractography 









4.4.1 Risk variants in NRG1 and ErbB4 associated with increased FA 




Chapter 5: White matter integrity and DISC1 
5.1 Introduction 
5.1.1 Evidence for the involvement of DISC1 in psychiatric disorders 
5.1.2 Functions of DISC1  
5.2 Methods 








5.3.2 Voxel-based analysis 
5.3.3 tractography 
5.4 Discussion 
5.4.1 DISC1 and possible interactions with genetic background 
5.4.2 The risk-allele at DISC1 rs821616 
5.4.3 Limitations 
 
Chapter 6: No association of the genome-wide supported ZNF804A SNP with white matter 
integrity 
6.1 Introduction 
6.1.1 ZNF804A is associated with task-independent functional connectivity 
6.2 Methods 
6.2.1 Study sample 
6.2.2 Voxel-wise analysis 
6.2.3 Small volume correction 
6.2.4 Region of interest analysis 
6.2.5 Tractography 




Chapter 7: General conclusions and implications for the future 
7.1 Summary of most important findings 
7.2 Methodological remarks and limitations 
7.3 Implications for the future 










Bipolar disorder (BD) is an affective disorder characterised by alternating periods of depression 
and mania. These periods of extreme mood typically last for weeks to months, and periods of 
mixed mood are also commonly experienced. During manic episodes, patients tend to be 
disinhibited with poor self-judgement resulting in risk taking and impulsivity, and domineering 
and discourteous social behaviour. Depressive episodes encompass feelings of worthlessness and 
hopelessness, lack of pleasure and motivation and social withdrawal. In BD, depressive episodes 
are associated with a suicide risk as high as 15%, which is higher than for unipolar depression 
(Müller-Oerlinghausen, 2002). The severity, range and frequency of BD symptoms can vary 
widely between patients, and the boundaries between healthy mood fluctuations and mild mood 
disorder is determined by the degree of functional impairment in addition to affective symptoms 
per se. Furthermore, despite a presumed predominance of affective symptoms, BD is not always 
clearly distinguishable from schizophrenia or other psychotic disorders and patients with BD 
commonly present with delusions and sometimes hallucinations. The current diagnostic criteria 
for manic and depressive episodes according to the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV) are summed up in Table 1.1. BD is categorised in bipolar I and bipolar II 
disorder. A diagnosis of bipolar I disorder requires at least one manic or mixed episode, whilst in 
bipolar II disorder patients have had at least one major depressive episode and at least one 
hypomanic episode, a milder form of mania (Table 1.1). 
Clearly, the symptoms of BD have a substantial impact on the patient's quality of life, his/her 
family and relationships, and professional ambitions. In between episodes, patients may be able 
to function well, and when treated successfully these euthymic periods can last for many years. 
Subclinical mood swings, cognitive disabilities and personality characteristics associated with 
the disorder or its medication, are likely to persist in spite of effective treatment. Although mood-
stabilising medications, often combined with anti-psychotics and/or psychotherapy, are 
successful in eliminating full-blown mood and psychotic episodes in up to 60% of patients 
(Geddes et al., 2004), the course of BD tends to be life-long. The underlying causes of BD are 
poorly understood, and this is the main obstacle for developing more effective treatments. 
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 Table 1.1: DSM-IV diagnostic criteria for episodes of mood disorder. 
Criteria for Major Depressive Episode 
A. Five (or more) of the following symptoms have been present during the same 2-week period and 
represent a change from previous functioning; at least one of the symptoms is either (1) depressed 
mood or (2) loss of interest or pleasure. 
1) depressed mood most of the day, nearly every day, as indicated by either subjective report 
(e.g., feels sad or empty) or observation made by others. 
2) markedly diminished interest or pleasure in all, or almost all, activities most of the day, 
nearly every day (as indicated by either subjective account or observation made by others) 
3) significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of 
body weight in a month), or decrease or increase in appetite nearly every day. 
4) insomnia or hypersomnia nearly every day 
5) psychomotor agitation or retardation nearly every day (observable by others, not merely 
subjective feelings of restlessness or being slowed down) 
6) fatigue or loss of energy nearly every day 
7) feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or guilt about being sick) 
8) diminished ability to think or concentrate, or indecisiveness, nearly every day (either by 
subjective account or as observed by others) 
9) recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a 
specific plan, or a suicide attempt or a specific plan for committing suicide 
B. The symptoms do not meet criteria for a Mixed Episode. 
C. The symptoms cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. 
D. The symptoms are not due to the direct physiological effects of a substance or a general medical 
condition. 
E. The symptoms are not better accounted for by Bereavement 
Criteria for Manic Episode 
A) A distinct period of abnormally and persistently elevated, expansive or irritable mood, lasting at 
least 1 week (or any duration if hospitalization is necessary) 
B) During the period of mood disturbance, three (or more) of the following symptoms have persisted 
(four if the mood is only irritable) and have been present to a significant degree: 
1) inflated self-esteem or grandiosity 
2) decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
3) more talkative than usual or pressure to keep talking 
4) flight of ideas or subjective experience that thoughts are racing 
5) distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli) 
6) increase in goal-directed activity (at work, at school, or sexually) or psychomotor agitation) 
7) excessive involvement in pleasurable activities that have a high potential for painful 
consequences 
C) The symptoms do not meet criteria for a Mixed Episode 
D) The mood disturbance is sufficiently severe to cause marked impairment in occupational 
functioning or in usual social activities or relationships with others, or to necessitate hospitalization to 
prevent harm to self or others, or there are psychotic features. 
E) The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a 






Table 1.1 (continued) 
Criteria for Hypomanic Episode 
A) A distinct period of persistently elevated, expansive or irritable mood, lasting throughout at least 4 
days, that is clearly different from the usual non-depressed mood. 
B) During the period of mood disturbance, three (or more) of the following symptoms have persisted 
(four if the mood is only irritable) and have been present to a significant degree: 
1) inflated self-esteem or grandiosity 
2) decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
3) more talkative than usual or pressure to keep talking 
4) flight of ideas or subjective experience that thoughts are racing 
5) distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli) 
6) increase in goal-directed activity (at work, at school, or sexually) or psychomotor agitation 
7) excessive involvement in pleasurable activities that have a high potential for painful 
consequences 
C) The episode is associated with an unequivocal change in functioning that is uncharacteristic of the 
person when not symptomatic. 
D) The disturbance in mood and the change in functioning are observable by others. 
E) The mood disturbance not severe enough to cause marked impairment in social or occupational 
functioning, or to necessitate hospitalization, and there are no psychotic features. 
F) The symptoms are not due to the direct physiological effects of a substance or a general medical 
condition. 
Criteria for Mixed Episode 
A. The criteria are met both for a Manic Episode and for a Major Depressive Episode (except for 
duration) nearly every day during at least a 1-week period. 
B. The mood disturbance is sufficiently severe to cause marked impairment in occupational 
functioning or in usual social activities or relationships with others, or to necessitate hospitalization to 
prevent harm to self or others, or there are psychotic features. 




Environmental and social factors undoubtedly contribute to the development of BD, but it is 
evident from post-mortem and brain imaging studies that BD is associated with abnormal brain 
structure and function. A wealth of magnetic resonance imaging (MRI) studies have 
demonstrated reductions in total brain volume, enlarged ventricles and increased volumes of 
certain sub-cortical structures. From meta-analyses of more than 250 studies, however, it appears 
that regional abnormalities in grey matter volume and density are less consistent (Arnone et al., 
2009; Kempton et al., 2008; Hallahan et al., 2011; McDonald, Zanelli et al. 2004). Over the last 
decades, MRI studies as well as histological post-mortem research across all disciplines, have 
focused predominantly on grey matter despite early findings of white matter hyper-intensities in 
BD. Recently, advances in imaging techniques such as functional connectivity and diffusion 
tensor imaging (DTI), along with a changing climate in neuroscience appreciating the brain as a 
functionally integrated system instead of a modular one, have encouraged research in functional 
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and structural connectivity. Psychotic and mood symptoms are increasingly understood in terms 
of deficient connectivity between brain regions, and evidence for compromised white matter 
structure in BD is compelling. 
There is also a significant genetic component to the causes of BD, as shown in twin, adoption 
and large pedigree studies. Although this is promising as treatment advances in many genetically 
complex medical disorders have greatly benefited from understanding their genetic causes, 
genetic research in psychiatric disorders seems to require more than classical association or 
linkage studies to discover genetic and molecular mechanisms. Measures that reflect brain 
structure or function can be useful as endophenotypes, which are assumed to be biologically 
closer and more sensitive to genetic variation than the clinical phenotype and which can assist to 
increase our understanding of the biological mechanisms underlying genetic risk. 
In this thesis I explore the relationship between genetic predisposition to BD and white matter 
integrity by means of DTI and the application of some of the most recent analysis techniques, 
including tract-based spatial statistics (TBSS) and tractography. These analyses are applied to a 
large sample of individuals with or without first-degree family member with BD. Genetic 
predisposition to BD was considered in two different ways: (1) having at least one first-degree 
relative with the disorder, and (2) carrying a risk-allele of a specific psychosis candidate gene. 
 
1.2 Genetics of bipolar disorder 
1.2.1 Heritability 
Identical twins of BD patients have an estimated 40%-70% risk to develop BD,  whereas the risk 
for dizygotic twins and non-twin siblings lies between 5.4% and 8% (Cardno et al., 2002; 
Craddock, O’Donovan & Owen., 2009; Gershon et al., 1982; Lichtenstein et al., 2009; McGuffin 
et al., 2003), compared to a general lifetime incidence of 0.5%-2% (Kessler, 1994). This 
translates to a heritability, defined as the variation in liability to BD attributable to genetic factors 
(h
2
), of around 80% (Gershon et al., 1982; McGuffin et al., 2003). There is marked overlap in 
heritability between unipolar depression and BD (Gershon et al., 1982; McGuffin et al., 2003), 
as well as between schizophrenia, bipolar and schizoaffective disorders, which is determined by 
genetic factors rather than shared environmental factors, as documented by twin (Cardno et al., 
2002) and adoption (Lichtenstein et al., 2009) studies. This shared genetic risk is also supported 
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by the observation that most of the well-established risk genes are not specific to a single 
psychotic disorder (Craddock, O’Donovan & Owen, 2006, 2009). Thus a large portion of genetic 
liability appears to be general to the “functional psychoses”, while environmental factors are 
likely to influence which specific symptoms will or will not develop (Lichtenstein et al., 2009). 
The distinction between environmental and genetic factors in these models is of course a 
complex issue since they interact and co-vary on many levels. For example substance abuse can 
obviously be considered “environmental”, but is also heritable in its own right (Bienvenu et al., 
2011) and is one of the most familial comorbidities of BD (Schulze et al., 2009). 
 
1.2.1 Linkage and association studies 
The well-documented high heritability for BD naturally prompts the search for the specific 
genetic loci that confer this liability. Generally, there are two ways of identifying genes related to 
a disorder or illness: through linkage in family-based study designs or through association in the 
general population. Briefly, in linkage studies one looks for co-segregation between a clinical 
phenotype and genetic markers spread across the genome. Linkage studies require the 
recruitment of one or more affected families, and can initially only detect larger chromosomal 
candidate regions and subsequent sequencing or association is required to map the co-
segregation pattern to a specific locus. Genetic association studies simply compare the frequency 
of an allele or haplotype between unrelated affected and non-affected individuals. In the past, 
single nucleotide polymorphisms (SNPs) had to be selected a priori, but with the advance of 
genome-wide association studies (GWAS) the whole genome can be tested for association to a 
phenotype by tagging hundreds of thousands of polymorphisms divided over linkage 
disequilibrium blocks. 
Over the years, many linkage studies have been performed in BD and even more in 
schizophrenia, and regions throughout the genome have been linked without clear consistency 
(Baron et al., 2002). Meta-analysis of linkage studies have not been able to improve this 
situation much, with one study reporting linkage in 6q and 8q and nominally in 9p and 20p 
(McQueen et al., 2005), another revealing significant linkage of 13q and 22q regions (Badner & 
Gershon, 2002), and a third finding no regions reaching genome-wide significance (Segurado et 
al., 2003). Bearing in mind that the strength of linkage studies lies in their ability to detect rare 
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variants of large effects and that these variants may in fact lie in different genes for different 
families, combining many families - let alone studies - may dilute the effect of family-specific 
variants. Studying a single, large family can be more sensitive to this type of effect. An example 
of such a design is the Scottish family that led to the discovery of the DISC1 gene (St Clair et al., 
1990; Blackwood et al., 2001), which is discussed in Chapter 5. 
Association studies complement linkage studies, both in terms of methodology and resulting 
inconsistencies. In the absence of whole-genome methods, initial association studies relied on 
knowledge about gene function and results from linkage studies to provide clues to a priori loci. 
Although association for the majority of resulting candidate genes have not been replicated, as 
highlighted in recent reviews (Barnett & Smoller, 2009; Craddock & Sklar, 2009; Serretti & 
Mandelli, 2008), there are a few genes for which the cumulative functional and association-
based evidence is convincing. These are NRG1, ErbB4, DISC1, BDNF, SLC6A4 and DAOA. The 
main functions of these are in neurodevelopment (NRG1, ErbB4, DISC1, BDNF), and plasticity 
(NRG1, ErbB4, DISC1, BDNF, DAOA) or serotonin transmission (SLC6A4). For their clear 
relevance to white matter development, myelination and maintenance of axon integrity NRG1, 
ErbB4 and DISC1 are extensively discussed in Chapters 4 and 5. 
There is a degree of randomness involved in this candidate gene approach and the scientific 
attention for a locus tends to fluctuate over time depending on novel findings in molecular 
neuroscience. As pointed out by Serretti and Mandelli (2008), a large number of potentially very 
interesting genes have not been studied in candidate studies, and similarly not all significantly 
linked regions have been followed up by candidate studies. Conversely, the current “risk genes” 
may appear more convincing than they are because these studies are very sensitive to publication 
bias. Genome-wide association studies, which enable the investigation of SNPs across the whole 
genome simultaneously, are more data-driven, and may therefore be a more objective way to find 
new causal genetic variation. However, studying the entire genome introduces a major multiple 
testing problem, which makes it extremely difficult to distinguish between true and false 
positives. Generally, stringent multiple testing corrections are applied to minimise false positives 
but at the same time they inevitably discard a large portion of the true signal. Fortunately, sample 
sizes are increasing, and even more importantly, they are being combined into massive GWAS 
collaborations and meta-analyses. With these, novel risk genes have been discovered, several of 
which were replicated in independent samples and have some apparent functional relevance to 
neuropathology, which is more than has been achieved for the majority of candidate genes over 
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the course of several decades. Replicated risk genes are DGKH, ANK3, CACNA1C, and 
ZNF804A (Baum, Akula et al., 2008; Baum, Hamshere, et al., 2008; Ferreira et al., 2009; Liu et 
al., 2010; O'Donovan et al., 2008; Sklar et al., 2008; Steinberg et al., 2011; Weber et al., 2011; 
Williams et al., 2011). As far as we know, CACNA1C is involved in plasticity through calcium-
signalling, ANK3 encodes a cell adhesion protein and DGKH interacts with the phosphoinositol 
pathway, which is an assumed therapeutic site of action of lithium (Manji & Lenox, 1999). Little 
is known about the immediate molecular function of ZNF804A apart from its association with 
functional connectivity during various cognitive activities and therefore its hypothetical 
involvement in structural connectivity, the details of which are discussed in Chapter 6. 
 
1.2.2 Missing genetic variation 
While the emergence of GWAS has revolutionised the field by both the discovery of new risk 
variants and the unbiased way genetic association can be quantified, the majority of the results 
do not replicate across studies. Also, the correspondence between the main linkage and 
association results is far from perfect, with NRG1 being the only well-supported risk gene 
mapping to a significant linkage region from the three meta-analyses, while DISC1 and ANK3 
each map to regions reported in two individual linkage studies which were not supported by any 
of the meta-analyses (Baron et al., 2002). The locations of ZNF804A, CACNA1C and ErbB4 do 
not map to any previously linked region. Furthermore, effect sizes of all candidate genes are 
small and altogether they explain only a small fraction of the heritability. What is more, an 
innovative method recently estimated the cumulative explained variance of the whole-genome at 
40% (Lee et al., 2011), suggesting that increasing sample sizes in univariate GWAS performed 
with current methods is undoubtedly going to reveal more common or rare risk variants, but they 
can probably never explain more than half of the genetic component. This is disconcerting 
because knowledge about the genetic variants that confer risk to a disorder or illness often leads 
to rapid progress in the understanding of its biology and consequently improved treatment, as 
evident in many other, non-psychiatric yet complex genetic conditions such as type II diabetes 
and Crohn's disease  (Manolio et al., 2008). 
Several explanations for the missing genetic variation in psychiatry have been proposed, and 
tremendous efforts are under way to explore these. Part of the problem could simply be that 
17 
 
some of the genetic variation is of such nature that it is extremely difficult to detect for statistical 
and epidemiological reasons. For example the detection of rare variants (SNPs, CNVs or larger 
chromosomal abnormalities) of large effect require well-designed family studies to see if the 
transmission of a variant correlates with the inheritance of the disorder. Another property that 
makes genetic variation difficult to detect is that psychiatric disorders are presumably polygenic: 
many common variants in numerous different loci are each responsible for a small increase in 
susceptibility. Studies that regress clinical phenotypes onto individual polygenic scores derived 
from independent genome-wide association samples indeed show that including many SNPs 
with relatively weak associations improves the explained variance of the regression model, 
especially in the case for bipolar disorder and schizophrenia (Evans et al., 2009; Purcell et al., 
2009).  Instead of a linear polygenic model, non-linear gene-by-gene interactions could explain 
the missing genetic variance. Some studies have indeed shown that selected risk variants have a 
larger effect in the presence of another known risk variant (e.g. Norton et al., 2006). But to do 
this in a genome-wide fashion exponentially inflates the multiple testing problem. 
If it is true that univariate analysis across the whole genome can explain a maximum of 40% of 
the liability to BD, explaining the remaining half of h
2
 may be aided by considering alternative 
forms of the measured phenotype. The clinical diagnostic phenotype is highly heterogeneous in 
both clinical and – most likely – aetiological terms, and inevitably includes some confounding 
effects of medication and state-related factors. The current diagnoses of BD, schizophrenia and 
other affective and psychotic disorders likely do not have a one-to-one relationship to the 
biological causes. For instance, there could be many subtypes of each disorder, each having their 
own biological cause. Alternatively it has been proposed that there is a psychosis-affective 
spectrum (e.g. Craddock, O’Donovan & Owen, 2009). In general, wherever the current 
psychiatric nosology bears an imperfect relation to genetic causes and other biological 
mechanisms, the consequences for genetic association studies are that variance of interest is lost 
and error variance is increased. There have been several attempts to relate genetic variation to 
symptom dimensions or severity, or to subgroups of psychiatric samples (reviewed in Craddock 
& Sklar, 2009), but these have produced mixed results. There is also no general consensus on the 
dimensions along which to subdivide samples, and replication will likely be more difficult with 
diagnostic scrutiny. 
From the above it can be concluded that (1) likely many genes have the potential to confer risk to 
psychiatric disorders, whether it concerns rare variants of large effects or common variants of 
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small effect or a combination of both; and (2) improving the biological validity and decreasing 
the complexity of the phenotype is necessary if we want to appreciate the complete genetic 
component of psychiatric disorders. Given that healthy individuals can easily carry one or more 
risk variants without the appearance of clinical disorder, searching for genetic associations with 
intermediate phenotypes, or endophenotypes, in healthy populations can be a powerful strategy. 
  
1.3 Endophenotypes 
An endophenotype is a reliably measurable trait that biologically lies more proximal to the 
underlying genetics of a disorder than the original phenotype (diagnosis) and is assumed to be 
more sensitive to genetic variation than diagnosis itself. There are five criteria for an 
endophenotype as defined by Gottesman and Gould (2003): (1) it must be associated with the 
disorder in the general population, (2) it must be highly heritable, (3) it must be independent of 
clinical state, (4) it must co-segregate with the disorder within families, and (5) it must also be 
apparent in unaffected relatives of individuals with the original phenotype. Not only can an 
endophenotype, once established, be a more statistically powerful measure in association studies 
or quantitative linkage studies, it can also fill in missing biological links between genes and 
clinical symptoms. If many different risk variants additively or synergistically confer risk to 
develop the same symptoms, it is probably because they feed into common biological pathways 
and processes. Endophenotypes are likely to capture the upstream effect of these common 
biological pathways, and will therefore be useful research constructs to further delineate relevant 
processes both downstream towards molecular genetics and upstream towards clinical 
neuroscience. 
Despite the clear potential value of endophenotypes, they have not yet been widely applied to 
psychiatric genetics nor have many been established as true endophenotypes according to the 
criteria of Gottesman and Gould. A reason may be that large family-based samples are required 
to firmly test the criteria that they are both present in unaffected relatives but to a lesser extent 
than in patients themselves, implying the effects in the relatives are subtle. Sample sizes in brain 
imaging studies are only recently beginning to increase towards N = 50 or more. However, 
proposed endophenotype candidates include behavioural, neurocognitive as well as 
neuroimaging phenotypes (Glahn et al., 2007, 2010; Hasler et al., 2006). Large amounts of 
neuropsychological data are relatively economical and reliable to acquire. As such, Glahn et al. 
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(2010) have shown robust endophenotypic qualities of verbal and facial memory and digit-
symbol substitution tasks. To achieve this, a complete neuropsychological test battery was 
administered in over 700 individuals from multiple families. To conduct brain imaging study of 
similar scale would be even more challenging. Nevertheless, there are a few promising brain 
imaging endophenotype candidates for which high heritability has already been estimated, and 
which are more or less consistently abnormal in patients. These include fMRI-based resting-state 
connectivity (Glahn et al., 2010), total brain, intracranial volumes, total white matter volume 
(van der Schot et al., 2009), local grey matter density (Thompson et al., 2001), and white matter 
integrity. Below I evaluate the current evidence for white matter as an endophenotype for BD. 
First I consider evidence for white matter pathology in BD as required by criterion 1, after which 
I discuss the remaining criteria. 
 
1.4 White matter pathology in bipolar disorder 
1.4.1. Hyper-intensities, histology and structural MRI in bipolar disorder 
The first indications for white matter abnormalities in the brains of patients with BD came from 
increases in hyper-intensities in deep white matter as visible on T2-weighted images of the brains 
of bipolar patients, and are the most widely reported features in the brains of bipolar patients 
(reviewed in Videbech 1997; meta-analyses in Kempton et al., 2008 and in Beyer et al., 2009). 
Histological studies of patients’ post-mortem brains have, similar to imaging studies, mostly 
focused on grey matter. However, density and counts of glia, and in particular oligodendrocytes 
which are responsible for axon myelination, within cortical regions are indicative of white matter 
pathology in bipolar patients (Ongur et al., 1998; Rajkowska et al., 2001; Uranova et al., 2004; 
Vostrikov et al., 2007). More direct evidence comes from one study showing reduced myelin 
staining in post-mortem brains of bipolar patients (Regenold et al., 2007). Furthermore, there is 
support from microarray studies showing altered glia- and myelin-related gene expression 
(Hakak et al., 2001; Tkachev et al., 2003). 
Early MRI studies of total cerebral or lobar white matter volumes in BD have provided mixed 
results, with four studies reporting significantly reduced volumes in bipolar patients and six 
negative studies (reviewed by Mahon et al., 2009). Others focused on the corpus callosum as a 
region of interest easy to segment in early MRI. Six out of the nine studies demonstrated 
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reductions in callosal total volume or within-slice area (reviewed by Mahon et al., 2009), the 
latter of which was highly significant in a meta-analysis by Kempton et al. (2009). 
More computationally advanced voxel-based morphometry (VBM) analyses of T1-weighted 
images have also demonstrated reductions in white matter density in patients with BD, although 
the locations of the findings vary widely. Significant reductions have been reported in the 
temporal and prefrontal lobes, especially surrounding the anterior limb of the internal capsules 
(ALIC) (Bruno et al., 2004; Chen et al., 2004; McDonald et al., 2005; McIntosh et al., 2005, 
2006). Some of these reductions have been confirmed in first-episode and medication-naïve 
patients (Atmaca et al.,2007; Rosso et al., 2007; Strakowski et al., 1993), suggesting that they 
are not merely a consequence of medication or the progression of the disorder. Nevertheless, 
several negative studies not finding any significant differences in any voxel locations also exist 
(Beyer et al., 2009; Sarnicola et al., 2009; Scherk et al., 2008). 
 
1.4.2. Diffusion tensor imaging in bipolar disorder 
Considering neuro-anatomical pathology is generally quite subtle in psychiatric patients, some of 
the above inconsistencies may be attributable to the sub-optimal sensitivity of the T1-weighted 
signal to white matter and the application of VBM, in which there can be a confusing trade-off 
between grey and white matter density as such that any reductions in white matter can often also 
be interpreted as increases in grey matter and vice versa. Moreover, this method is very 
susceptible to partial volume effects, is dependent on subjective segmentation parameters, and 
although it may detect gross volumetric differences is also relatively insensitive to 
microstructural differences on a smaller scale. DTI is an innovative approach to measure white 
matter integrity that is based on the anisotropic diffusion of water molecules along (rather than 
across) white matter fibres. The degree of this anisotropy is commonly quantified by fractional 
anisotropy (FA) and is assumed to reflect the overall integrity of white matter structure (for 
details see Chapter 2). Not only is FA, as derived from DTI scans, sensitive to white matter 
microstructure, DTI also allows for more advanced analysis tailored to white matter anatomy 
(see Chapter 2). 
DTI studies have repeatedly shown FA reductions in patients with BD, although the locations of 
these vary widely. Integrating DTI findings by cerebral location is difficult because of the variety 
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in methods ranging from voxel-based to tract-based methods, from tractography to cortical and 
sub-cortical ROIs. Confusingly, the latter are frequently confined to predominantly grey matter 
regions, without further reference to the meaning of FA in a voxel classified as grey matter. 
Nevertheless, roughly combining results from over twenty-five DTI studies performed in BD so 
far, it is clear that white matter integrity reductions have been reported in every lobe, nearly 
every anatomical tract as well as in or underneath most Brodmann areas (as reviewed in Heng et 
al., 2010; Mahon et al., 2009 and Sexton et al., 2009). Overall, FA reductions have been most 
consistent in temporal and frontal areas and their connections, including the genu of the corpus 
callosum, the anterior thalamic radiation (ATR) and the uncinate fasciculus (UF) (Vederine et al., 
2011). In these regions, reductions were also confirmed in first episode patients (Adler et al., 
2006), indicating they are not merely a result of medication or of progressive aspects of the 
disorder. Confusingly, there are also some indications for white matter increases in the left UF 
(Houenou et al., 2007; Versace et al., 2008; Wessa et al., 2009; Yurgulun-Todd et al., 2007). It is, 
however, possible that these increases are attributable to the partly neuroprotective effects of 
lithium and some anti-psychotic medications. 
Overall, histological, radiological and more advanced imaging techniques strongly suggest that 
subtle white matter pathology is present in BD, as required by the first criterion of 
endophenotypes. Despite advances in DTI, enabling the modeling of white matter microstructure 
in vivo, some difficulties in interpretation of the imaging findings remain. For example, it is not 
entirely clear whether the connectivity in UF is increased or decreased in BD; or whether the 
decreased integrity in bipolar patients is a global effect or specific to one or more restricted white 
matter regions. Some of these contradictions between studies can be attributed to a combination 
of sample heterogeneity, medication effects, illness progression and effects specific to temporary 
mood state (Arnone et al., 2009; Kempton et al., 2008); the same issues that should be resolved 
by the consideration of endophenotypes. 
 
1.5 White matter as an endophenotype for bipolar disorder 
The heritability of structural MRI-derived brain measures vary with brain structure, age and 
intellectual ability (Chiang, et al., 2009; Chiang, McMahon et al., 2011, Kochunov et al., 2010; 
van der Schot et al., 2009, 2010). A first twin study revealed that the heritability of total white 
matter volume is highly significant, estimating h
2 
at 74%, which is also considerably higher than 
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that of total grey matter volume estimated at (60%) (van der Schot et al., 2009). A subsequent 
VBM study revealed that h
2
 was highest for white matter density in the frontal lobes with h
2
 
estimates up to 74% (van der Schot et al., 2010). DTI studies are in agreement with this, with 
heritability of whole-brain FA estimated at (52%), with maxima in frontal and corpus callosum 
tracts (h
2
 up to 66%). For younger people, up to mid-twenties, and those from a high socio-
economic background, FA is more heritable still, and reaches h
2 
estimates of 85% in frontal and 
callosal regions (Chiang et al., 2009; Chiang, McMahon et al., 2011). Furthermore, bivariate 
modelling has shown that a significant part of genetic risk for BD is explained by variance in 
white matter volumes and density, whereas grey matter is associated with the (unique) 
environmental component of BD (van der Schot et al., 2009, 2010). Together these studies 
provide ample evidence that white matter volume and integrity are heritable, as required by 
endophenotype criterion (2). 
For criterion (3) - the endophenotype should be independent of (temporary) state - there is no 
direct evidence, as this technically requires a longitudinal DTI study in patients.  The stability of 
white matter abnormalities is, however, cross-sectionally supported by their presence in 
euthymic, manic and mixed patients, which also include first-episode patients (e.g. Adler et al., 
2005; Benedetti et al., 2011; Wang, Jackowski et al., 2008; Wang, Kalmar et al., 2008). 
A few imaging studies, including in our own research group, have conducted structural MRI in 
unaffected relatives of bipolar patients. Two of these found an inverse correlation between white 
matter density or volume and genetic liability scores based on family history (McDonald, 
Bullmore et al., 2004; Mcintosh et al., 2006). In the study by our group (McIntosh et al. 2006), 
this association was located in the left inferior frontal lobe and the ALIC. The results of 
McDonald were more distributed and included the corpus callosum, the left deep parietal white 
matter (around the arcuate fasciculus; AF), and the right superior parietal white matter. In a 
direct comparison between unaffected relatives and a control sample, however, no reductions 
were found in unaffected relatives who had more than two first-degree relatives with 
schizophrenia or BD, but there were two small frontal regions in which there were reductions in 
those with at least one relative with each disorder (McIntosh et al., 2005). 
Three DTI studies have investigated white matter in unaffected relatives of BD, but none of 
these can be considered conclusive. Chaddock et al. (2009) did not detect any significant FA 
difference in a direct voxel-wise contrast of unaffected relatives and patients. However, this may 
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be due to insufficient statistical power (19 patients, 21 relatives, 18 controls), as they did find a 
correlation of genetic liability scores with FA in 70 clusters distributed over the whole brain 
(which was the principal component). Frazier et al. (2007) did find localised FA reductions in 
unaffected children of bipolar patients aged 4 to 12 years, but they failed to apply appropriate 
corrections for multiple comparisons and given the age and the sample size (10 patients, 7 
relatives, 8 controls) these results cannot be readily generalised. The most recent study, by 
Versace et al. (2010), concerned children between the ages of 8 and 18 years, at a time window 
of profound developmental changes in white matter. For children under the age of fourteen, 
Versace et al. (2010) noted increased FA in the unaffected relatives compared to controls, while 
the opposite was true for those older than fourteen. From the viewpoint of BD as a 
neurodevelopmental disorder, this is a very interesting finding (as further discussed in Chapter 3), 
but it is not so informative when evaluating white matter as an endophenotype. Thus, although 
no imaging studies provided conclusive evidence for criterion (5), they are all suggestive of 
reductions in individuals at high risk for BD. This is also supported by the finding mentioned 
above: genetic factors explain at least 38% of the covariance between white matter volume and 
BD (van der Schot et al., 2009). 
To summarise, white matter integrity is a promising endophenotype candidate for BD: (1) as 
evident from histology, radiology and advanced imaging techniques white matter structure is 
compromised in patients, (2) white matter volume and integrity are highly heritable, and (3) 
since white matter reductions have been found in euthymic and first-episode patients, it appears 
to be state-independent. Although correlations with genetic vulnerability scores suggest the 
presence of white mater abnormalities in unaffected relatives, direct evidence for criterion (5) is 
lacking. On the other hand, the same studies were able to convincingly show reductions in the 
patients themselves, in support of criterion (4). 
 
1.6 White matter in relation to current neuro-cognitive models of psychosis 
1.6.1. Emotion regulation 
In general, current models of BD focus on inadequate regulation of activation in limbic and 




proposed that emotion dysregulation arises from disrupted prefrontal modulation of the striatum 
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and the amygdala-hippocampal complex. This model can be extended by that of Phillips et al. 
(2003a, 2003b, 2008) which divides the emotional system into voluntary and automatic 
processes. The former depend on a “dorsal” system which includes hippocampus and dorsal 
prefrontal regions, while the latter rely on a “ventral” neural network comprised of several 
temporal lobe structures (the amygdala, insula), the ventral striatum and ventromedial prefrontal 
regions. A special role is attributed to the orbitofrontal cortex, which may serve as a “hub” to 
modulate the connection between the two systems. Akin to this is the model by Ochsner and 
Gross (2005), who also divide the top-down emotional processes into a dorsal and a ventral 
prefrontal network. However, in this model the main function of the dorsal network is 
“description-based” (the attribution of emotional value and internal representation to a stimulus), 
whereas the ventral network's function is “outcome-based”. The precise functions and 
integrations of each sub-system within each model are disputable, but they clearly both 
emphasise the importance of functional and structural connectivity in larger brain networks in 
accordance with the current climate in cognitive neuroscience which has moved from “functional 
segregation” to “functional integration” (Friston, 1999; Friston & Frith, 1995). 
A healthy functional integration of emotional networks is naturally dependent on the structural 
integrity of its connections. According to the above models these involve mainly fronto-temporal, 
fronto-thalamic and fronto-stiatal connections. In terms of white matter anatomy, the direct 
connections between these regions are the UF, AF, ATR and cingulum bundles (CING). As 
reviewed above, these relevant connections have been implicated in structural imaging studies of 
BD. However, the striatum, thalamus and orbitofrontal cortex are potential “hubs”, meaning they 
can be intermediate stations between any two regions.  Consequentially, changes in white matter 
integrity in other connections could also indirectly influence each neural network. 
 
1.6.2. Neurodevelopment and plasticity 
A striking proportion of the genes currently implicated in BD and schizophrenia are involved in 
neurodevelopment or plasticity, each of which have been proposed to be central to psychosis, 
although more often in schizophrenia (Friston, 1999; Harrison & Weinberger, 2005). These 
processes have most often been related to grey matter but they are equally - if not more - fitting 
with a role for white matter as mediator of genetic effects. Firstly, grey matter peaks around the 
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age of 10 to 12 years, while white matter continues to mature in, and potentially beyond, late 
adolescence and early twenties, especially in fronto-temporal connections (DiGiorgio et al., 2008; 
Lebel et al., 2008; Paus et al., 2005; Pfefferbaum et al., 1994) approximately matching typical 
age of onset of psychosis. Secondly, synaptic plasticity itself by definition occurs in grey matter, 
but axonal integrity and the degree of myelination control the speed of signal transduction which 
is crucial for the initiation of long-term potentiation. Furthermore, activity-dependent structural 
changes are not limited to the synapse, but also occur in white matter (Demerens et al., 1996; 
Fields, 2008). The mutual dependence between structural and functional connectivity, grey and 
white matter plasticity and their shared genes and molecular pathways, suggests a web of 
mechanisms in which various disruptions can cause symptoms and mental disorder. As partly 
inferred from the more abundant research in schizophrenia and grey matter, a role for white 
matter in this web is highly conceivable, however relatively under-appreciated so far. 
 
1.7 Summary and aims 
Over the last decade interest in white matter has increased due to the development of advanced 
imaging techniques and the view of the brain as a functionally integrated system, and evidence is 
accumulating that white matter integrity is compromised in BD. Family and genetic studies 
suggest white matter integrity can be an endophenotype of BD, although there are uncertainties 
about the location and nature of white matter abnormalities in bipolar patients and their relatives. 
Diffusion tensor imaging in a sufficiently large, unmedicated sample of unaffected relatives can 
clarify previous inconsistencies and explore the validity of white matter as an endophenotype for 
BD, and potentially provide clues to the mechanisms of specific candidate genes. 
Here, I present a comprehensive DTI study of white matter integrity in individuals at high 
genetic risk for developing BD. First, I established whether FA is reduced in unaffected relatives, 
as part of testing its validity as an endophenotype (Chapter 3). Then, I directly tested associations 
between FA and candidate genes, chosen on the basis of their combined functional and statistical 
evidence in association with BD and their functional relevance to white matter (Chapters 4, 5 
and 6). To investigate these questions thoroughly, a number of advanced analysis techniques 








2.1 Principles of diffusion MRI 
2.1.1. Diffusion MRI 
DTI is an MRI application that depends on the random motion of water molecules (“diffusion”) 
due to thermal energy and its restriction and hindrance by body tissue. Normally, in an 
unrestricted and unhindered environment, molecules move randomly in all directions (“random 
walk”), resulting overall in isotropic diffusion. For a sufficiently large number of molecules, the 
mean squared displacement ((r−r0)²) of a molecule in a uniform substance is directly proportional 
to the time interval t, as shown in Einstein's equation [2.1]. The diffusion coefficient D depends 
on the substance in question (e.g. water) and the temperature of the sample. 
 
(r−r0)² = 2 Dt                  [2.1] 
 
In a diffusion MRI sequence, two strong pulsed magnetic field gradients are used to measure the 
mobility of water molecules. In its simplest form, the sequence for diffusion MRI contains an RF 
excitation pulse, followed by two opposite (separated by an 180
o
 refocusing RF pulse) pulsed 
magnetic field gradients separated by a time interval. Because of these gradients, the phase angle 
of the proton spin depends on their location. As a consequence, if the water molecules do not 
move during the time interval, the signal recorded after the second gradient will be equal to the 
signal obtained in the absence of any temporary gradients. However, as we know, the water 
molecules do move, and the more they move, the more the proton spins are out of phase and the 
lower the resulting signal will be. Thus, the amount of signal attenuation in a voxel reflects the 




2.1.2. The diffusion tensor and derived measures 
Importantly for DTI, the random motion of molecules in a human body is hindered and restricted 
by tissue properties such as membranes and organelles. The anatomical architecture of white 
matter, with long and thin axons organised in bundles and insulated with myelin sheaths gives 
rise to a distinctly anisotropic diffusion pattern. In an abstract sense, one can think of isotropic 
diffusion, as in equation [2.1], as a sphere with a radius D, and of anisotropic diffusion as an 
ellipsoid with its long axis parallel to the principal axon direction (see Figure 2.1). In 
mathematical terms, the three-dimensional molecule displacement is best represented by a 
diffusion tensor, D, defined by a symmetrical matrix as in equation [2.2]. 
 
           [2.2] 
    
 
This quantity provides information on both the magnitude and directionality of water molecule 
displacement in three-dimensional space. To determine D for a given voxel, multivariate linear 
regression is used to estimate the six unknown variables, Dxx, Dyy, Dzz, Dxy, Dxz and Dyz, from the 
signal intensities generated from each diffusion gradient direction and the b-value (strength of 
diffusion-weighting). Since there are six unknown variables, the DTI sequence has to be repeated 
at least six times, with diffusion gradients applied in six non-collinear directions. In practice, 
often more than six gradient directions are applied to increase reliability and signal-to-noise, and 
to allow for probabilistic tractography (see below). Acquiring more than six diffusion directions 
allows the probability distribution of each of the six tensor variables to be estimated, thereby 
incorporating an estimate of the uncertainty caused by MRI noise, local anatomical properties 
and imaging artefacts on the principal diffusion direction. This gives a much better 
representation of reality, and can be important for certain types of analysis, such as tractography 
(Behrens et al., 2003). 
From the diffusion tensor, a number of useful biomarkers of white matter integrity can be 
calculated. This is achieved by diagonalising the diffusion tensor into three eigenvectors, which 
represent the orthogonal diffusion directions in each voxel (v1, v2, v3), and their corresponding 
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eigenvalues (λ1, λ2, λ3), which represent the magnitude of the diffusion along each orthogonal 
direction as depicted in Figure 2.1. 
 
Figure 2.1. The diffusion tensor as a model of white matter microstructure.  
(Adapted from Newcombe et al., 2007) 
 
 
The first biomarker, mean diffusivity (MD), represents the overall magnitude of diffusion and is 
equal to the average of the eigenvalues (λ1, λ2, λ3). In the brain, MD is highest in cerebrospinal 
fluid, since the motion is not restricted by tissue and lower in both white and grey matter. The 
second common biomarker provided by DTI is the fractional anisotropy (FA), which quantifies 
the degree of diffusion anisotropy, and indicates the weighted deviation of each of the three 
eigenvalues from MD. The formula to obtain FA is given by equation [2.3]. 
     
      [2.3] 
 
 
Since anisotropic diffusion is what distinguishes white matter best, FA is the most commonly 
used measure for approximation of white matter integrity, and it is the outcome measure of 
interest for most of the analyses presented in this thesis. Other quantifications of anisotropy also 
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exist, such as relative anisotropy, but these are not as commonly used because their scales are 
less sensitive to the variation within white matter (Hasan et al., 2004). Finally, both axial and 
radial diffusivity are often used as measures of interest. Axial diffusivity is defined as the 
primary diffusion eigenvalue (λ1) and reflects water displacement along fibres. Radial diffusivity 
is the perpendicular motion and is computed as the average of the second and third eigenvalues 
(λ2, λ3). 
 
2.1.3. Validity and anatomical sources of diffusion measures 
In DTI, diffusion is measured at a scale of millimetres while the anatomical restrictions to 
diffusion are at the scale of microns. Hence, the diffusion tensor is only a model of the anatomy 
we aim to measure. We can therefore not be sure of the microstructural anatomical source of 
variation in FA and other measures on the basis of DTI data alone, and this source can easily 
vary between locations and individuals. White matter has several anatomical properties that in 
theory can influence the degree of diffusion anisotropy: the presence of axon organelles and cell 
membranes hinder the intracellular diffusion across the axon, myelin restricts the diffusion, the 
density and parallel-ness of the fibres influence the scope of extracellular diffusion and the axon 
diameter has the potential to speed up the diffusion in the parallel direction. From animal models 
of multiple sclerosis and experimentally induced white matter pathology and post-mortem 
studies that combine DTI with histology, we know that FA is probably sensitive to each of the 
above anatomical properties (Deboy et al., 2007; Gouw et al., 2008; Klawiter et al, 2011; Li et 
al., 2011; Schmierer et al., 2007). Thus, FA can be seen as a non-specific measure that 
approximates the overall integrity of white matter. 
Efforts have been made to distinguish between myelin-related pathology and axonal damage 
using DTI. In general, there is a belief that increases in radial diffusion (i.e. perpendicular to 
axon) may reflect myelin pathology, whereas decreases in axial diffusion (i.e. parallel to axon) 
imply axonal damage. In a series of mice experiments, Song et al. (2002, 2003, 2005) provided 
some evidence for a double dissociation between de-myelination and axonal damage and their 
respective effects on radial and axial diffusivity. Although axial and radial diffusivity are 
currently readily interpreted according to these distinct pathologies in DTI studies, claims of the 
distinct sensitivity of axial and radial diffusivity for myelin and axon integrity, should be 
interpreted with caution (Wheeler-Kingshott & Cercignani, 2009). A first problem is that axonal 
damage and myelination are dynamic processes, partly dependent on each other, and separating 
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them in in vivo experiments is difficult. The most important problem, however, is that both axial 
and radial diffusivity are absolute measures of distance, and therefore highly dependent on the 
overall density and permeability of local tissue, which is in turn sensitive to many processes that 
typically co-occur with axon damage and de-myelination in vivo, and with the experimental 
procedures used to induce them in animals. These can include inflammatory responses of all 
kinds such as microglia accumulation, intra- and extracellular oedema and scar formation, and 
there is evidence that some of these other processes are better correlated with axial and radial 
diffusivity over time than axonal and myelination pathology (Xie et al., 2010). This view is also 
in line with the absence of any associations between axial and radial diffusivity with specific 
pathology in ex vivo scans of the spinal cord (DeBoy et al., 2007; Klawiter et al., 2011), and with 
the observation that the predictive value of axial and radial diffusivity on pathology type is 
dependent on the type of injury inflicted on the animal (Budde et al., 2007). 
Although in certain (clinical) circumstances it can be extremely valuable to be able to distinguish 
between different white matter pathologies, considering the uncertain validity of axial and radial 
diffusivity, these biomarkers are not considered here. For the purpose of the present study of 
brains with relatively unknown pathology, it was more important to have a reliable and validated 
outcome measure that has repeatedly been shown to be sensitive to insults in structural white 
matter integrity under various circumstances such as relative anisotropy (RA) and FA (Budde et 
al., 2007; Cercignani et al., 2001; DeBoy et al., 2007; 2010; Gouw et al., 2008; Kim, Budde et 
al., 2006; Li et al., 2011MacDonald et al., 2007; Schmierer et al., 2007; Song et al., 2003; 2005; 
Underwood et al., 2011).While I have applied a number of DTI analysis techniques to study 
white matter, FA is the outcome measure of choice for each of these - whether within voxels or 
averages extracted from ROIs. The main analysis procedures I have performed are later on in 
this chapter. 
 
2.2 The Bipolar Family Study 
2.2.1.  Participants and clinical and neuropsychological assessments 
The Bipolar Family Study is a large, prospective study of individuals at high genetic risk for BD, 
conducted in Edinburgh. The “high risk” participants have at least one first-degree or two 
second-degree relatives with a clinical diagnosis of bipolar I disorder, although most have more 
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than one family member with a diagnosis of an axis I psychiatric disorder. The dataset contains 
MRI scans, including DTI, and blood samples as well as extensive clinical and 
neuropsychological assessments at two time points, with an approximate 2 year interval. All 
analyses in this thesis are performed on the first assessments only, as the follow-up was still 
being conducted at the time of this project. Here follows a description of the recruitment of 
participants, the materials used and the sample characteristics in general. For the subsequent 
analyses described in the results chapters, different exclusion criteria may have been used 
depending on the nature of the analysis (e.g. for analysing the effects of genes, only one 
individual per family was used; and for the initial group comparison they were matched on IQ), 
so the samples differ slightly across chapters. Because of this, further details of sample 
demographics for each analysis are given in each result chapter. 
Patients with a clinical diagnosis of bipolar I disorder were identified from the case loads of 
psychiatrists across Scotland. Each patient was asked to identify members of their close family 
aged 16-25 years and to consent to either a review of their case notes or to a structured clinical 
interview. The diagnosis of all affected subjects was then confirmed using the Structured Clinical 
Interview for DSM-IV (SCID), or the operational criteria (OPCRIT) check list for psychotic 
illness (McGuffin et al. 1991).  Following informed consent, unaffected relatives of the proband 
with at least one first degree, or two second degree relatives with bipolar I disorder were then 
invited to participate in the study. Wherever possible, to optimise matching on key confounds, 
controls were recruited from the social networks of the high-risk subjects themselves. Written 
informed consent was provided by all participants and the study was approved by Committee A 
of the Multicentre Regional Ethics Committee for Scotland. 
All participants were interviewed by a trained psychiatrist (AM McIntosh, JE Sussmann) using 
the SCID, the Hamilton scale for Depression (HDRS), and the Young Mania Rating Scale 
(YMRS). Individuals who fulfilled SCID criteria for an axis-I psychiatric disorder, including 
substance dependence, were excluded from further analyses. Additional exclusion criteria were 
major neurological disorders, history of head injury, history of learning disability and metallic 
implants or other contraindications to MRI examination. 
Of the unaffected relatives contacted to participate in the study, eighty-one refused to participate 
or were ill at recruitment. A total of 259 young people took part in the study: 150 unaffected 
relatives and 109 healthy controls. Seven participants in the high-risk group were diagnosed with 
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an axis-I disorder after recruitment, and were excluded from further analysis. A further 26 
unaffected relatives and 12 control participants were excluded for all analyses in this thesis 
because either no DTI data had been collected or because of severe imaging artefacts (movement, 
braces, etc.). This left 117 unaffected relatives and 97 healthy control participants for further 
analysis.  
HDRS and YMRS scores indicated that lifetime mood and psychotic symptoms were virtually 
absent in our sample. Only HDRS scores differed significantly between the groups, but a lifetime 
absence of a depressive episode, or other axis I disorder, was confirmed in all participants 
included in the final sample. Substance abuse for cannabis, sedatives/anxiolytics, stimulants and 
hallucinogens was assessed on five-point ordinal scales based on the SCID interview: one for 
current (last month) and one for past substance use.Alcohol and nicotine use were assessed 
separately, respectively by self-report of units per week and cigarettes per day. Full-scale IQ was 
measured using the Wechsler Abbreviated Scale of Intelligence (WASI; Psychological 
corporation, 1999), which consists of four subtests of the Wechsler Adult Scale of Intelligence to 
measure non-verbal/performance IQ (block design and matrix reasoning) and verbal IQ 
(vocabulary and similarities). The main reason for the use of full scale IQ in this thesis was to 
exclude the possibility of confounding on other outcome measures either by ensuring subgroups 
of our sample were well-matched, or by including IQ as a covariate in statistical models. 
 
2.2.2.  Scan Acquisition and Pre-processing 
All MRI data were collected on a GE 1.5 T Signa Horizon HDX (General Electric Milwaukee, 
WI, USA) clinical scanner equipped with a self-shielding gradient set (22mT/m maximum 
gradient strength) and manufacturer-supplied 'birdcage' quadrature head coil. Whole brain DTI 
data were acquired for each subject using a single-shot pulsed gradient spin-echo echo-planar 
imaging (EPI) sequence.. Diffusion gradients (b = 1000 s/mm²) were applied in 64 non-collinear 
directions to increase the signal-to-noise ratio and to allow for probabilistic tractography. Fifty-
three 2.5 mm contiguous axial slices were acquired with a field-of-view of 240  240 mm, 
acquisition matrix of 96  96 (zero-filled to 128  128), given an isotropic acquisition voxel 
dimension of 2.5 mm. In addition, 7 T2-weighted EPI baseline scans were collected as part of the 
DTI sequence. Finally, a separate T1-weighted volume was acquired for each participant with the 
33 
 
following acquisition parameters: acquisition matrix 192  192, voxel dimension 1.25  1.25  
1.20 mm, 180 slices, time of inversion 500 ms, echo time 4 ms and flip angle 8°. 
The diffusion MRI data were converted to 4D NIfTI-1 (http://nifti.nimh.nih.gov) volumes and 
pre-processed using tools available from FSL (http://www.fmrib.ox.ac.uk/fsl). First, the data 
were corrected for eddy current induced distortions produced by the strong diffusion-encoding 
gradients in the EPI sequence and bulk subject motion by registering the diffusion weighted 
volumes to the first T2-weighted EPI volume within each subject. This was followed by 
extraction of brain tissue, as performed by “BET” in FSL, using a fractional intensity threshold 
of 0.3. Then diffusion tensor characteristics were calculated, including principal eigenvectors 
and FA values, using DTIFIT. The quality of all resulting FA maps was visually checked, and 
images showing severe artefacts were excluded from further analyses. Whenever there was doubt 
about the quality of an image, an experienced MR physicist (ME Bastin) was consulted. 
 
2.2.3. Genotyping 
DNA was extracted from venous whole-blood samples. Genotypes at selected DISC1, NRG1, 
ErbB4 and ZNF804A SNPs were determined at the Wellcome Trust Clinical Research Facility in 
Edinburgh (http://www.wtcrf.ed.ac.uk) using TaqMan polymerase chain reaction (PCR, TaqMan, 
AssayByDesign, Applied Biosystems, Foster City, USA) using validated assays. In brief, two 
types of probes, each designed to contain one of the possible alleles at the SNP of interest, anneal 
to one of the DNA strands. Each type of probe has its own fluorophore on one end and a 
quencher on the other. A primer is designed to anneal to the DNA downstream from the SNP, and 
the attachment of a polymerase enzyme to the primer induces PCR (meaning it synthesises a new 
strand of DNA, complimentary to the existing strand, starting from the primer). When the PCR 
gets to the probe, it breaks down the probe and the fluophore is released. The resulting amount of 
fluorescence shows the amount of DNA containing the probe target allele so that heterozygotes 
will show an approximate equal amount of each type of dye, while homozygotes will have about 





2.3 Whole-brain statistics 
2.3.1. Tract-based Spatial Statistics 
Although FA maps are in principle suitable for voxel-wise statistics, for example in SPM 
(http://www.fil.ion.ucl.ac.uk/spm), after co-registration and spatial smoothing, there is 
considerable individual variability in white matter structure, which in places is very thin or 
characteristically shaped, and therefore this method is sensitive to mis-registration and partial 
volume effects. Tract-based spatial statistics (TBSS; Smith et al., 2006) is a method especially 
designed for voxel-wise analysis of FA data. The unique feature of TBSS is that for each 
individual a white matter “skeleton” is created, which is assumed to represent the centres of the 
white matter structure for each person. This skeleton projection step alleviates the effect of mis-
registration, smoothing thresholds and the non-normal distribution of FA values (Zalesky, 2011). 
 
Figure 2.2.The mean FA skeleton mask template (green) used as template for TBSS, overlaid on 




TBSS was carried out using standard tools in FSL (http://www.fmrib.ox.ac.uk/fsl/tbss/) and 
according to the recommended protocol (Smith et al., 2007). First, all subject's FA volumes 
resulting from the processes described in section 2.2.2 were non-linearly registered to a standard 
template using FNIRT. Second, a mean of all registered FA volumes was calculated and a white 
matter skeleton template was created. Upon visual inspection, a threshold of FA > 0.2 was 
applied to the FA skeleton template to exclude predominantly non-white matter voxels (Figure 
2.2). Third, for each subject's FA volume, at each point on the skeleton the maximum voxel 
perpendicular to the local skeleton direction was projected onto the skeleton. This skeleton 
projection step is performed according to two rules: (1) when a “maximum” voxel is near two 
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skeleton points, it can only be projected onto the one closest to it, and (2) a Gaussian kernel 
weights each voxel's FA according to its distance from the skeleton so that far away voxels are 
less likely to be “chosen”. This results in one FA skeleton map per subject, which is assumed to 
contain anatomically corresponding centres of white matter structure. These skeletons, overlaid 
on each subject’s FA map, were checked by eye to ensure they were located in each subject’s 
white matter. Voxel-wise statistics were then be performed on the skeletons, as described in 
detail below. In this work, I also frequently used FA averaged over the whole skeleton which 
proved very useful as a single outcome estimate for general white matter integrity. 
 
2.3.2. Threshold-free cluster enhancement 
In the present work, voxel-wise statistics were mostly performed using non-parametric T-tests or 
regressions in FSL “randomise”. As with any voxel-wise analyses, whole skeleton analysis 
causes a massive multiple testing problem, and without corrections will inevitably lead to many 
false positive findings. In these datasets, statistics were performed on each of the 137832 voxels 
in each skeleton. Simply dividing the critical p-value by this number would be overly 
conservative since FA is correlated between neighbouring voxels and would unnecessarily inflate 
false negative findings. There are now many possible solutions for multiple testing problems in 
whole-brain analysis that take this spatial correlation into account, and many even take 
advantage of it. 
In general there are two ways statistics can be considered in whole-brain analysis: at a single 
voxel-level and at a cluster level. The former tests the significance of each separate voxel, and is 
therefore sensitive to a large effect in a single location. In this case, the p-value of a voxel can be 
corrected for multiple testing by estimating the smoothness of the image, which gives the 
number of independent signals (“resels”) which can then be corrected for using family-wise error 
(Bonferroni) or false discovery rate (Bullmore et al., 1999) methods. On the other hand, cluster-
based methods (Friston et al., 1993; Bullmore et al., 1999) are based on the logic that if many 
consecutive voxels show a similar effect, the effect is less likely to be a mere coincidence than if 
they are in random locations all over the brain. An advantage of the cluster-based methods is that 
they are sensitive to more subtle effects as long as they are spatially consistent, a type of effect 
that is probably more realistic in most situations than a large effect at a single voxel. In practice, 
cluster-wise statistics are typically computed by thresholding a T-map with an initial, arbitrary 
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threshold, and testing the significance of the cluster-size of supra-threshold voxels against a null 
distribution. This null-distribution can be estimated using random-field theory (Bullmore et al., 
1999; Friston et al., 1993). However, such theoretical null-distributions for cluster sizes are not 
always accurate, especially in data with non-uniform smoothness (non-stationarity), small resels 
and small sample sizes, and when low initial thresholds are applied (Hayasaka & Nichols, 2003; 
Hayasaka et al., 2004; Salimi-Khorshidi et al., 2011; Silver et al., 2011). Moreover, the latter 
also reduces sensitivity to subtle, widespread signals which was the main reason for using 
cluster-based methods in the first place. 
Threshold-free cluster enhancement (TFCE; Smith & Nichols, 2009), retains the sensitivity to 
subtle widespread signals of cluster-based thresholds, but does not require the arbitrary choice of 
an initial threshold. If followed by permutation-based estimation of a null-distribution, the above 
problems of cluster-wise testing are mostly resolved. In practice, each T statistic is converted 
into a TFCE value that represents both the local effect size (or “height”) and the extent of 
adjacent voxels “supporting” this signal (“extent”), according to equation [2.4] 
       
              [2.4]
   
Where h is the “height”, e(h) is the extent given this height, and E and H are parameters to weigh 
these factors, typically set at 0.5 and 2 respectively. In practice, the “heights” of all supporting 
voxels are added to obtain the TFCE score of a particular voxel. In this process the height is 
increased from h0 (usually 0) to h of the voxel in question, which is also the maximum h that can 
be contributed by any supporting voxel. As such, the local specificity of the voxel is retained 
while incorporating the spatial consistency of the signal. 
Similar TFCE maps are calculated for each permuted dataset, and the maximum TFCE values 
make up the empirical null-distribution. At each voxel, the p-value is then the proportion of 
permuted TFCE values exceeding the unpermuted TFCE value, which is equal to the probability 
that one would obtain the observed TFCE statistic by chance alone. In this work, I applied TFCE 
to the TBSS skeletons, as available in the “randomise” tool from FSL, with 5000 permutations 
per contrast. For all whole-brain analysis, results are considered significant only at levels of p < 












voxels) and localised to anatomical structures using DTI-based white matter atlases, built in FSL 





Whole-brain (or whole-skeleton) voxel-wise comparisons of FA are useful methods to determine 
differences in white matter integrity between a clinical group and a control group, especially in 
the absence of knowledge about the locations of potential abnormalities. However, even with the 
application of TBSS, registration errors are still present (Zalesky et al., 2011). The confidence 
that a voxel in one subject corresponds to the same anatomical structure in another subject can be 
increased by segmenting specific tracts in native space. Although one can segment particular 
regions of interest by hand, this is very demanding and subjective work. Tractography algorithms 
are automatic or semi-automatic methods to segment specific tracts of interest based on DTI data. 
Although many different algorithms have been developed to date, they all rely on the directional 
information available from the diffusion tensor, and they require one or more seed points and 
termination criteria to stop tracing when approaching grey matter or cerebrospinal fluid. In its 
most basic form, a simple deterministic streamline approach, an algorithm starts from a given 
seed voxel in the centre of the tract of interest from where it follows the primary diffusion 
direction (v1) to the appropriate adjacent voxel. This procedure continues until a termination 
criterion is reached. Obviously, the same procedure is performed in the other direction from the 
seed point, and the algorithm is usually repeated for multiple seed points in the same tract. 
Information is retained about which voxels have been visited by the streamline(s), and average 
FA or other summary metrics of interest can be extracted from them. 
 
2.4.2. Probabilistic Neighbourhood Tractography 
More sophisticated tractography algorithms, such as BedpostX/ProbTrackX are not deterministic, 
but incorporate probabilistic information on the diffusion direction by acquiring the diffusion 
MRI data with more than 6 diffusion gradient directions and modelling the signal as a 
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combination of a purely isotropic and several anisotropic (fibres) compartments  (Behrens et al., 
2003). From a single seed point they can then sample thousands of streamlines with different 
endpoints. A resulting connectivity map provides information about the likelihood that the voxels 
are “connected” to the seed voxel. Importantly, one has to keep in mind that the whole method is 
still based on the relatively large scale at which DTI data is acquired, and that “structural 
connectivity” remains no more than a model of the underlying axonal shapes and connections. 
But although tractography is no replacement for histology, methods such as 
BedpostX/ProbTrackX have produced convincing connectivity maps that correspond very 
closely to known anatomy from histological examinations (Behrens et al., 2003; Johanssen-Berg 
et al., 2005). A further advantage of probabilistic tractography algorithms is that they can model 
more than one fibre direction in a voxel and are potentially able to track through regions of low 
anisotropy, features which are not available to the diffusion tensor model (Behrens et al., 2007). 
 
Figure 2.3. Processing pipeline for probabilistic neighbourhood tractography. 
 





Thus, applying the BedpostX/ProbTrackX algorithm improves the quality of tractography results 
and is more faithful to reality by incorporating the uncertainty inherent in diffusion MRI data. 
But on in isolation, this method is still influenced by the (subjective) placements of the seed 
points. A complementary algorithm, neighbourhood tractography (Clayden et al., 2006; 2009) 
alleviates this problem by performing ProbTrackX seeded from multiple “neighbourhood” seeds, 
and automatically selecting the “best” seed point based on the similarity of the resulting tract to a 
pre-determined atlas-based reference tract (Muñoz Maniega, Bastin et al., 2008). The procedure 
of this method is graphically shown in Figure 2.3. In brief, the seed point from the reference tract 
in standard space is transformed to the subject's native space, using the inverted (standard space 
to native space) transformation matrix obtained from FSL's FLIRT algorithm (Jenkinson & 
Smith, 2001). ProbTrackX is applied to each of a neighbourhood of surrounding voxels 
(commonly: 7  7  7) to create a set of “candidate tracts”. The spatial median of each of these 
candidate tracts is compared using a tract-shape modelling algorithm, which calculates a 
posterior probability of the candidate tract matching the reference tract for shape and length. This 
posterior probability is determined by the angles between each of a number of b-splines on both 
reference and median candidate tract; and on the similarity in tract length. (Clayden et al., 2006).  
The best seed point is then chosen and the respective streamlines (typically 5000) from this seed 
point are then pruned to only retain the ones for which inclusion improves the “statistical fit” to 
the reference tract. This pruning effectively removes streamlines that deviate too much from the 
original median line (Clayden et al., 2009). 
The voxels that are visited by one or more streamline after all these processes are combined into 
a binary mask, and the average FA is extracted from them and weighted according the proportion 
of streamlines going through the voxel (reflecting the probability a voxel belongs to the tract). 
This final FA value is now assumed to be a good representation of the integrity of the tract of 
interest and can subsequently be compared between groups of people or correlated with a 
measure of interest. The scan-rescan reproducibility of FA values resulting from probabilistic 
neighbourhood tractography is reasonably good (coefficient of variations between 3.9 and 7.2), 
although somewhat depending on the tract of interest (Clayden et al., 2006). Probabilistic 
neighbourhood tractography has been integrated with BedpostX/ProbTrackX by Jonathan 




Figure 2.4 Examples of tracts included 
in the analysis. Typical examples 
shown for all tracts of interest: genu 
(a), splenium (b), corticospinal tract 
(c), arcuate fasciculus (d), cingulum 
bundle (e), anterior thalamic 















Figure 2.5 Examples of tracts 
excluded from the analysis. 
Examples are shown for the 
corticospinal tract (a), arcuate 
fasciculus (b), cingulum bundle (c), 
anterior thalamic radiation (d), and 
uncinate fasciculus (e). No tracts 






















2.4.3 Tractography applied to the Bipolar Family Study 
Using TractoR, I applied BedpostX/ProbTrackX in combination with probabilistic 
neighbourhood tractography to the bipolar high-risk data for the following tracts of interest: the 
genu and splenium of the corpus callosum, the bilateral anterior thalamic radiations (ATR), 
arcuate fasciculi (AF), cingulum bundles (CING), uncinate fasciculi (UF) and corticospinal 
tracts (CST). I used 5000 streamlines per tract per seed, and a 7  7  7 voxel neighbourhood 
leading to 343 candidate tracts per tract of interest. 
The resulting tracts were visually inspected, and tracts that obviously deviated from known 
anatomy or were severely truncated were excluded. The most common reason for exclusion was 
for tracts to branch out into the territory of other tracts, and for this a threshold of 5% was 
employed (i.e. > 5% of streamlines, after pruning, determined using the tractography atlas; Mori 
et al. 2005). The numbers of subjects excluded for each tract are detailed in Table 2.1. The genu 
and splenium in the corpus callosum were successfully traced for all subjects, but it was 
necessary to exclude up to 19% and 13% of the participants for the left UF and left ATR 
respectively. The other tracts encountered few problems, with fewer than 9 exclusions per tract. 
The number of exclusions for left ATR and UF were statistically independent of group (Fisher’s 
p = 0.86; p = 0.16, respectively), suggesting it has probably not caused significant bias to the 
analysis in Chapter 3. Examples of included and excluded tracts are depicted in Figures 2.4 and 
2.5. 
Table 2.1 Numbers and proportions of successfully traced tracts. 
 HC % HC HR % HR ALL % ALL 
Genu 97 100 117 100 214 100 
Splenium 97 100 117 100 214 100 
AF left 93 95.8 113 96.6 206 96.3 
AF right 96 99.0 110 94.0 206 96.3 
ATR left 86 88.7 101 86.3 187 87.4 
ATR right 96 99.0 115 98.3 211 98.6 
CING left 95 97.9 111 94.9 206 96.3 
CING right 96 99.0 112 95.7 208 97.2 
CST left 95 97.9 116 99.1 211 98.6 
CST right 96 99.0 115 98.3 211 98.6 
UF left 83 85.6 91 77.8 174 81.3 




The most common reason for exclusion of the ATR was branching into the genu of the corpus 
callosum. The ATR is a large tract with fibres “radiating” out into different directions from the 
thalamus, which likely introduces a lot if individual variation in tract shape. Also, ATR anatomy 
has a lot of potential to cross other fibres especially those of the genu. For the left UF, again 
branching into the corpus callosum was a common problem, which happened in 22 subjects. But 
for this tract additional problems were also encountered including branching in the ATR or other 
tracts, and severe truncation. The UF has relatively low FA, and has relatively few fibres, and 
thus streamlines are more likely to move into nearby voxels with higher FA values that are part 
of other tracts. Like the ATR, the UF crosses many other fibres including those of the genu, the 
inferior longitudinal fasciculus and the fronto-occipital fasciculus. It is unclear why tracings of 
the right ATR and UF were more successful than the left, but other colleagues have verified this 










As discussed in Chapter 1, BD is associated with white matter abnormalities in the brain, some 
of which have also been found in unaffected relatives of patients. DTI is currently the most 
widely used and regarded as the most accurate method of studying white matter integrity in vivo. 
However, to date it is unclear if white matter integrity reductions, as measured by DTI, are 
present in unaffected relatives of patients with BD. Here, I set out to test this important criterion 
for white matter as an endophenotype. In addition, I investigate whether white matter integrity is 
related to cyclothymic temperament, which is thought to be genetically related to BD and which 
might underlie the bipolar spectrum (Akiskal & Akiskal, 2005). Three previous studies have 
measured FA in unaffected relatives (Chaddock et al., 2009; Frazier et al., 2007; Versace et al., 
2010), all of which were suggestive of white matter integrity reductions in relation to genetic risk 
for BD. However, as reviewed in Chapter 1, due to methodological and demographic issues the 
results of these cannot be readily generalised. 
Cyclothymia, as a dimension of temperament in the healthy population, reflects the affective 
stability of a person. It has been suggested that cyclothymic temperament is a fundamental trait 
underlying the bipolar spectrum, and that it plays a role in the predisposition to affective 
disorders (Akiskal & Akiskal, 2005). Since cyclothymia scores of individuals at high genetic risk 
are intermediate between patients and controls (Mendlowicz et al., 2005; Chiaroni et al., 2005), 
cyclothymic temperament could also be a potential endophenotype for BD.  
I used TBSS, tractography and conventional voxel-wise analyses to compare FA in a large 
sample of unaffected relatives of patients with BD with a large number of individuals without a 






3.2 Materials and Methods 
3.2.1 Study sample and data acquisition 
Participants were recruited, clinically and neuropsychologically assessed and scanned as 
described in Chapter 2. To match the unaffected relatives and the healthy controls on IQ, 19 
individuals in the control group with the highest IQ scores were excluded from the present 
analyses. For this chapter, the total sample consisted of 197 subjects, including 117 unaffected 
relatives and 79 controls. The groups were matched on all other demographic variables of 
interest, including age, sex and history of substance abuse (Table 3.1). 
 
3.2.2 Cyclothymic temperament 
Scores for cyclothymic temperament were obtained by administration of the abbreviated version 
of the Temperament Evaluation of Memphis, Pisa and San Diego auto-questionnaire (TEMPS-A; 
Akiskal, Mendlowicz et al., 2005). The abbreviated TEMPS-A is a self-report questionnaire 
consisting of 39 items, 12 of which exclusively load on a cyclothymia factor. The cyclothymia 
factor has excellent internal consistency (Crohnbach’s α=0.91), is the best represented factor of 
the abbreviated questionnaire (Akiskal, Mendlowicz et al., 2005), and has high test-retest 
reliability (Spearman’s coefficient = 0.84) in the original TEMPS-A (Matsumoto et al., 2005). 
Although in addition to the cyclothymia factor, the anxiety factor of the TEMPS-A scale was 
also increased in unaffected relatives, I did not analyse the anxiety factor because it is only 
represented by 3 items in the abbreviated questionnaire and has a lower reliability (Akiskal, 
Mendlowicz et al., 2005). 
 
3.2.3 TBSS 
The TBSS skeletons were obtained as described in Chapter 2. Voxel-wise comparisons between 
high-risk and the control groups were performed using T-tests in ‘randomise’ in FSL. All 
reported TBSS results are corrected for multiple testing at p < 0.05 using TFCE in FSL. 
Associations with cyclothymic temperament were examined by adding log-transformed 





examinations were conducted to validate the results further. Firstly, in some cases more than one 
high-risk participant was recruited per affected family, therefore not all observations were 
statistically independent. In order to test for robustness against this non-independence both group 
and cyclothymia analyses were repeated leaving in only unrelated individuals, randomly selected 
for each family. In addition, because TFCE results indicated a widespread effect of FA, FA 
values were averaged over the whole skeleton for each subject for further analysis in SPSS. 
Finally, to investigate whether results could have been driven by differences in white matter 
volume; each subject’s total white matter volume was calculated on the basis of the T1-weighted 
scan, using a standard segmentation script in SPM5 and compared between groups using a T-test 
in SPSS. 
 
3.2.4 Voxel-based analysis 
The TBSS group comparison was cross-validated using more conventional voxel-based statistics 
on the whole brain FA-maps. This analysis compares FA values throughout the brain and does 
not utilize a common white matter skeleton. For this analysis, FA volumes created by the DTIFIT 
were non-linearly co-registered using the FNIRT toolbox. Subsequently, images were smoothed 
with a smoothing kernel with FWHM = 12 mm, as recommended by Jones et al. (2005). A mask 
was created by averaging all FA volumes and thresholding at FA > 0.15. Voxel-wise comparisons 
were performed on all voxels within the mask using ‘randomise’ with the TFCE option. Results 
are reported corrected on the whole-brain level according to TFCE, using permutation testing 
(5000 permutations, p < 0.05). White matter regions were localised to specific regions and/or 





Table 3.1: Demographics, clinical characteristics and history of substance abuse. 
Variable HC HR Statistic P value 
NS / NF 79 / 79 117 / 93   
Age (SD)1 20.78 (2.27) 21.03 (2.75) T = -0.65 0.52 
IQ (SD)1 108.88 (10.42) 106.50 (13.66) T = 1.36 0.18 
Sex3     
   Male 37 (46.8 %) 55 (47.0 %) χ² < 0.01 0.98 
   Female 42 (53.2 %) 62 (53.0 %)   
Handedness3     
  Left 7 (8.9 %) 8 (6.8 %) χ² = 0.30 0.59 
  Right 70 (88.6 %) 107 (91.5 %)   
  Unknown 2 (2.5  %) 2 (2.0 %)   
Occupation parent3     
  Manual 32 (40.5 %) 52 (44.4 %) χ²= 0.55 0.46 
  Non-manual 38 (48.1 %) 49 (41.9 %)   
  Unclassified 9 (11.4 %) 16 (13.7 %)   
Cyclothymia2 * 1 (0 – 5) 2 (0 – 6) U = 3033 0.04 
HDRS2 * 0 (0-1) 0 (0-3) U = 3653 0.02 
YMRS2 0 (0-0) 0 (0-0) U = 4038 0.07 
Substance use     
  Alcohol (SD, units/wk)2 15 (0 – 33) 10 (0 – 27) U = 4023 0.16 
  Cigarettes3 24 (31.2 %) 42 (35.9 %) χ² = 0.46 0.50 
      if yes: cig/day (SD)2 10 (1 – 19) 10 (0 – 21) U = 498 0.94 
   Cannabis3 53 (67.9 %) 81 (69.2 %) χ² = 0.04 0.85 
   Stimulants3 25 (32.1 %) 37 (31.6 %) χ² < 0.01 0.95 
   Hallucinogenic3 15 (19.2 %) 21 (17.9 %) χ² = 0.05 0.82 
   Opiates3 2 (2.6 %) 6 (5.1 %) NA 0.31 
   Sedatives3 4 (5.1 %) 12 (10.3 %) NA 0.16 
1
group means and standard deviations for variables normally distributed; 
2
medians and interquartile 
ranges for variables not normally distributed; 
3
frequency and percentages for categorical variables. 
HC = Healthy control group, HR = High risk group, NS: number of subjects; NF: number of families; NA: 













Probabilistic neighbourhood tractography was performed according to the methods explained in 
Chapter 2. In SPSS, two types of mixed-model regressions were applied: (1) a large mixed 
model regressing the between-subject variable ‘group’ and within-subject variables ‘tract’ and 
‘hemisphere’ on the dependent variable FA; and (2) for each tract of interest with hemisphere as 
the within-subject factor, group as the between-subject factor, and average FA within the 
segmented tract as the dependent variable. As detailed in Chapter 2, some subjects were 
excluded for specific tracts due to truncation, excessive branching, and severe deviation from 
known anatomy. In addition, a few extreme outliers (> 3 standard deviations) were also removed. 
This led to 2 missing values for the genu, 1 for the splenium, 7 for the left AF, 7 for the right AF, 
22 for the left ATR, 3 for the right ATR, 7 for the left cingulum, 5 for the right cingulum, 2 for 
the left CST, 2 for the right CST, 28 for the left UF and 1 for the right UF. The advantage of 
using mixed-model regressions in this respect is that they allow for the unilateral exclusion of a 
value whilst retaining the data for the other hemisphere. Associations with cyclothymic 
temperament were tested for by adding log-transformed cyclothymia scores to each of the mixed 
regression models above. 
Comparing FA for these tracts in seven regressions, naturally comes with the risk of inflated type 
I error due to multiple testing. A simple Bonferroni-based correction can be calculated by 
dividing 0.05 by 7 resulting in a corrected significance threshold of 0.007. However, in this 
specific situation there are a few factors that alleviate the probability of type I error and make the 
Bonferroni adjustment overly conservative: (1) FA is highly correlated between tracts (Penke et 
al., 2011); (2) if there are any significant effects in the first large regression model it indicates a 
true effect is present, whether it is be a subtle effect over all tracts together or caused by one or 
more tracts in particular; and (3) correspondence of tractography results with the location of the 
voxel-wise results would increase confidence in a significant effect being  a “true” effect. For 
these reasons, initially uncorrected p-values are reported, followed by a discussion of their 
validity with respect to Bonferroni-corrected significance levels and correspondence with voxel-






3.3.1 Group Comparison: voxel-wise analysis 
TBSS followed by TFCE resulted in one large, diffuse cluster (K = 46 101 voxels, pFWE < 0.05) 
extending over most of the white matter skeleton, including the corpus callosum, internal and 
external capsules (including ATR), inferior and superior longitudinal fasciculi, inferior fronto-
occipital fasciculi, uncinate fasciculi, parts of the CST and subcortical white matter around the 
central sulci (Figure 3.1). Around two thirds of these voxels (K = 29 292) were still significant 
when the corrected significance level was made more stringent at pFWE< 0.01. There were no 
clusters in which FA was increased in the high-risk group compared to the controls for any 
voxel-wise analysis. 
Similar results were obtained after random removal of related siblings in the unaffected relatives 
group, again with a cluster covering most of the skeleton (K = 35 820 voxels) significant at 
pFWE< 0.01. Although the groups were well-matched on all demographic variables, additional 
analyses confirmed that these results were not confounded by age, IQ or sex: a widespread 
cluster of reduced FA remained after including these variables in the design matrix (K = 41 921; 
pFWE < 0.05).  
Furthermore, the post-hoc analysis of average FA extracted across the whole skeleton revealed 
that FA was significantly reduced in the unaffected relatives compared to controls (T = 2.87, p = 
0.005). The groups did not differ significantly in total white matter volume (T = 0.55, p = 0.58). 
And again in line with the TBSS results, the voxel-based analysis conducted without a white 
matter skeleton also indicated reduced FA in the unaffected relatives (K = 387 442 voxels, pFWE< 
0.05) compared to controls (Figure 3.2). 
 
3.3.2 Group comparison: Tractography 
Results of the different mixed-model regressions of group on FA are summarised in Table 3.2. 
Figure 3.3 and Table 3.3 summarise the average FA for each tract, comparing the high-risk group 
to the control group. The first large regression model for all tracts together revealed a significant 
effect of group on FA (F = 8.135, p = 0.005). This is a reflection of FA being lower in the high 




the voxel-wise results (Figures 3.1 & 3.2). As can be expected, main effects of tract and 
hemisphere were also observed, but more importantly there were no group-by-tract or group-by-
hemisphere interactions. However, separate regressions for each tract revealed that the effect was 
certainly stronger in some tracts and nearly absent in others. 
To summarise Figure 3.3 and Table 3.2, there was a highly significant effect of group on FA in 
the AF (F = 13.595, p < 0.001) across both hemispheres, which comfortably survives a 
Bonferroni correction at p < 0.007 (0.05 / 7 tracts). There was also a nominally significant effect 
of group on FA in the genu (F = 4139, p = 0.043). For the other tracts, none of the differences 
were significant. The only tract giving some indication for a group-by-hemisphere interaction 
was the ATR (F = 2.229, p = 0.137), with a trend for the left ATR (T = 1.748, p = 0.065) but not 
for the right. All of these tractography results remained similar when co-varying for age, sex and 











Figure 3.1. TBSS results of the group comparison. TBSS revealed reduced FA in the high-risk 
group compared to the control group in one large cluster (K= 46 101 voxels; PFWE < 0.05). For 





Figure 3.2. Voxel-based result of the group comparison. Voxel-based analysis revealed reduced 
FA in unaffected relatives of patients with bipolar disorder compared to the control group in 
one large cluster extending over most parts of the white matter (K = 387 442 voxels, pFWE< 0.05). 
The images are in radiological convention. 
 
 
Figure 3.3. Tractography results of the group comparison. Tractography revealed significant FA reductions in the AF and the genu of the 
corpus callosum of the unaffected relatives of patients with bipolar disorder. Overall, there were no tracts in which FA was increased in the 
unaffected relatives and a large mixed model also revealed an overall effect of group in the absence of group-by-tract or group-by-




Table 3.2. Results of mixed regressions  
LARGE MODEL: Group Tract Hem 
   F=8.135 (p=0.005)* F=391.687 (p<0.001) F=0.147 (p=0.701) 
 groupXtract Group X Hem Hem X Tract Group X Tract X Hem 
 1.110 (p=0.353) F=0.815 (p=0.367) F=47.001 (p<0.001) F=0.215 (p=0.930) 
 
BY TRACT: Group Hemisphere Group X Hem 
 AF F=13.595 (p < 0.001)* F=8.927 (p=0.003) F=0.039 (p=0.843) 
 ATR F=1.759 (p=0.186) F=20.170 (p<0.001) F=2.229 (p=0.137) 
 CING F=0.016 (p=0.899) F=114.899 (p<0.001) F=0.001 (p=0.974) 
 CST F=1.989 (p=0.160) F=96.340 (p<0.001) F=0.820 (p=0.366) 
 UF F=1.594 (p=0.208) F=2.978 (p=0.086) F=1.611 (p=0.206) 
 GENU F=4.139 (p=0.043)* - - 
 SPLENIUM F=2.330 (p=0.128) - - 
 Statistics in bold are significant under a Bonferroni-type correction (p-value multiplied by number of unilateral tracts; See text) 
Hem=Hemisphere; AF=arcuate fasciculus; ATR=anterior thalamic radiation; CING=cingulum bundle; CST=cortico-spinal 
tract; UF=uncinate fasciculus;  
  
Table 3.3. Simple effects per unilateral tract (corresponding to Figure 3.3) 
Means per group, statistics and standardised effect sizes (Cohen's d) 
   
TRACT 
HC HR Statistics 
Mean SE Mean SE T df p d 
genu 0.55531 0.00503 0.54503 0.00456 1.490 192 0.138 0.215 
splenium 0.56755 0.00744 0.55502 0.00747 1.188 193 0.236 0.171 
left AF 0.50295 0.00446 0.48717 0.00374 2.694 187 0.008* 0.394 
right AF 0.49445 0.00357 0.47785 0.00314 3.460 187 0.001* 0.506 
left ATR 0.37758 0.00338 0.36839 0.00362 1.855 172 0.065 0.283 
right ATR 0.38604 0.00384 0.38401 0.00327 0.401 191 0.689 0.058 
left CING 0.47091 0.00581 0.47058 0.00451 0.045 187 0.964 0.007 
right CING 0.42595 0.00696 0.42476 0.00491 0.140 189 0.889 0.020 
left CST 0.49118 0.00549 0.47978 0.00421 1.665 192 0.098 0.240 
right CST 0.52640 0.00515 0.52258 0.00450 0.566 192 0.872 0.082 
left UF 0.42212 0.00399 0.41326 0.00319 1.748 156 0.083 0.280 
right UF 0.42336 0.00362 0.42115 0.00320 0.451 193 0.652 0.065 
Note that the main analyses were not performed on simple effects per unilateral tract, but as mixed regres-
sions, across hemispheres (and tracts). This table is included to provide meaningful effect sizes that allow for 
comparisons across studies, not for assessing the statistical significance of the present findings per se. The 





3.3.3 Cyclothymic Temperament: voxel-wise analysis 
Unaffected relatives had significantly higher cyclothymia scores than the controls (U = 3033, p 
=0.04; log-transformed: T= 2.06, p = 0.04). Voxel-wise association of cyclothymia scores with 
FA within the TBSS skeleton revealed three clusters in which FA was negatively associated with 
cyclothymia (Figure 3.4). The largest one (K = 10 128 voxels, pFWE < 0.05) consisted of the 
internal capsules bilaterally connected via deep sub-thalamic white matter; and two smaller 
clusters (K = 236 voxels, K = 2 voxels, both at pFWE < 0.05) in the left hemisphere containing 
several fronto-temporal and fronto-thalamic connections including the external capsule, inferior 
longitudinal fasciculus, anterior parts of the left AF, dorsal left UF as well as left occipital white 
matter.  After random removal of related siblings, a trend for the effect of cyclothymia remained, 
with similar results to the full sample when the significance level was relaxed to pFWE< 0.08. 
The between group difference in FA was also significant in this analysis in three clusters (K= 9 
349, K=250 and K=198 contiguous voxels, pFWE< 0.05) mostly in the right hemisphere and the 
corpus callosum, indicating that the group effect is at least partly independent of the cyclothymia 
effect. There were no voxels in which there was a significant interaction between group and 
cyclothymia scores (all pFWE> 0.40). 
 
Figure 3.4. Negative association of FA with cyclothymic temperament. TBSS results for the effect 
of cyclothymia on FA, corrected for the effects of group, showing effects in the bilateral  internal 
capsules and in the left temporal white matter. For better visibility the results are thickened 




3.3.4 Cyclothymic temperament: Tractography 
The large mixed regression model including cyclothymia scores revealed no significant effect of 
cyclothymia scores on overall FA, and no interactions with tract, hemisphere or group.  Effects 
of group, tract and hemisphere all remained significant, as in the model without cyclothymic 
temperament. Separate regressions per tract resulted in significant negative associations of 
cyclothymic temperament on FA in the AF bilaterally (F = 9.847, p = 0.002, Figure 3.5) and 
more nominally in the UF (F = 4.414, p = 0.037), in the absence of any interactions with 
hemisphere or group. Again, the result in the AF comfortably survives Bonferroni correction at p 
< 0.007, but the one in the UF does not. And yet again the only tract giving any indication of 
laterality was the ATR with a significant cyclothymia-by-hemisphere interaction effect on FA (F 
= 4.211, p = 0.042), which was caused by a negative association of cyclothymia with FA in the 
left ATR (T = -2.025, p = 0.045) but not in the right. 
 
3.4 Discussion 
Here, I report widespread reductions in white matter integrity in our sample of unaffected 
relatives of patients with BD. These findings support the notion of white matter integrity as an 
endophenotype of BD, and suggest that impaired white matter integrity may be one of the 
underlying mechanisms of genetic predisposition to BD. In addition, I demonstrate an 
association between cyclothymic temperament and white matter integrity in specific temporal 
and fronto-thalamic regions, further supporting the view that white matter abnormalities have 
behavioural associations that are related to the symptomatology of the clinical disorder. 
 
3.4.1 White matter and genetic risk for BD 
As reviewed previously, others have found white matter abnormalities in unaffected relatives of 
patients with BD, most of them using white matter density or volume derived from T1-weighted 
MRI scans. Kiesappä et al. (2003) reported reduced left hemisphere white matter volumes in the 
unaffected twins of BD patients, McIntosh et al. (2005)
 
found that unaffected relatives of 
patients had reduced white matter density in prefrontal areas, and McDonald et al. detected an 




Figure 5.3. Negative association of cyclothymic temperament with FA in the left and right 
arcuate fasciculus (AF).  
 
AF = Arcuate Fasciculus; cycl = cyclothymic score; group 1 = control group; group 2 = high risk group. 
 
 
and temporo-parietal regions (McDonald, Bullmore et al., 2004). Two previous DTI 
studies of relatives of bipolar patients applied voxel-based analysis of whole brain FA 
values. Frazier et al. (2007) compared seven unaffected relatives with eight controls and 
found reduced FA in two clusters in the superior longitudinal fasciculi. However, the ex-
tremely small sample size, the lack of adequate correction for multiple comparisons, the 
very young age of the participants (4-12 years) and the presence of axis I disorders and 
other comorbidities in the majority of the children greatly limited the interpretation of 
that first study. In another DTI study, Chaddock et al. (2009) did not detect any differ-
ences contrasting twenty-one relatives to eighteen controls, but found that genetic liabil-
ity was associated with widespread FA reductions. Finally, Versace et al. (2010) applied 
TBSS to a group of children of patients with BD . Although in these unaffected children, 




their main finding was an interaction with age where FA in the high risk group decreased 
with age whilst in the control group it increased leading to an overall reduction of FA in 
those at high risk over the age of fourteen. Overall, our results of widespread FA reduc-
tions are most in line with the negative correlation of FA with a genetic risk score re-
ported by Chaddock et al. (2009) although their sample may have been too small to de-
tect this in a direct group contrast. The results of Frazier et al. (2007) and Versace et al. 
(2010) were much more confined to specific regions, albeit they did not agree, and this 
may be explained by statistics. First, our sample was much larger leading to an increase 
in statistical power which may be why we found more extended reductions than the stud-
ies by Frazier et al. (2007) and Versace et al. (2010). Furthermore, the other studies did 
not apply TFCE, and therefore would have required larger effect sizes within any given 
voxel to reach significance. Given the late development of some white matter tracts, an-
other important difference with both of these previous studies is age: Frazier et al. (2007) 
studied FA in children as young as 4 years old and Versace et al. (2010) adolescents were 
between 8 and 17, whilst the unaffected relative in Chaddock’s study were on average 
about twenty years older than our participants. These age differences may not only affect 
results in the case of age-by-group interactions, but also in terms of clinical characteris-
tics of the samples because the younger the children are, the less confident one can be 
they will be unaffected as the typical age of onset has not been reached. 
Another advantage of our study compared to previous studies is in the application of three 
different analyses methods, and the ability to corroborate voxel-wise results with tractography. 
The latter enables localisation to specific tracts and does not require co-registration, thereby 
better accounting for anatomical variability between individuals. Overall, the results of the three 
methods corresponded well and all indicated subtle but widespread FA reductions in the high risk 
group. However, tractography clearly indicated a large effect in the AF and modest effects in the 
genu, and could not confirm effects in other regions. On the other hand, the absence of any 
interactions between tract and group effects in the large mixed model seems to imply the effect, 
however small, is consistent across tracts. This is also visible in Figure 3.3, where most tracts 
display a distinct group difference in FA albeit non-significant. Whilst TFCE is a strict method 
for correction of multiple testing, it allows for quite substantial differences in effect sizes across 




consecutive voxels with similar tendencies. Altogether, the three methods suggest widespread,  
but in places subtle, FA reductions in the unaffected relatives, and any discrepancies between 
tractography and the voxel-wise methods in “significant” and “non significant” locations can be 
explained by the underlying statistics (TFCE vs. univariate statistics). In line with the idea of 
globally reduced FA, unaffected relatives also had lower FA averaged over the whole skeleton. 
This measure of whole brain white matter integrity is also estimated to have high heritability (> 
50%), and has been associated with mood-related genetic variation using quantitative trait 
linkage analysis (Kochunov et al., 2010). For these reasons this summary measure could be 
particularly useful in delineating multivariate genetic effects on white matter. 
 
3.4.2 White matter and cyclothymic temperament 
Here, the term temperament is used to describe a relatively stable, non-pathological trait to 
describe individual differences both in the healthy population and in clinical populations. In this 
context, cyclothymia has been described as defining “a subaffective disorder as well as a 
temperament” (Chiaroni et al., 2005). According to the theory by Akiskal and others cyclothymic 
temperament is one five affective temperament dimensions that together define a continuous 
space of affective stability and reactivity onto which the general population as well as the entire 
spectrum of affective disorders could be mapped (e.g. Akiskal & Akiskal, 2005). To what extent 
this overall continuum theory is true, and moreover, to what extent cyclothymic temperament is 
phenomenologically and biologically similar to bipolar disorder (as its presumed extreme), is a 
matter of debate. However, several studies at least provide support for the internal consistency, 
test-retest reliability (stability), power to predict recurrent depression, power to disciminate 
between unipolar and bipolar disorders, and correlations with quality of life measures in both 
healthy and patient populations (Matsumoto et al., 2005; Mazzarini et al., 2009; Nilsson et al., 
2012; Vasquez et al., 2008). Furthermore, the finding that unaffected relatives of bipolar patients 
have increased cyclothymic temperament suggests it may share a genetic component with BD 
(Vasquez et al., 2008). In this chapter I do not make assumptions about the phenomenological 
and theoretical relationship of cyclothymic temperament to clinical BD, but the following 
discussion interprets the results under the more narrow assumption that cyclothymic 




Using TBSS I found a negative association between cyclothymic temperament and white matter 
integrity in the internal capsules bilaterally and in the left temporal lobe, across both high-risk 
subjects and controls. Following tractography, the association with FA in the temporal regions 
appeared in the UF and the AF, bilaterally. In contrast, the effect in the ATR, which runs through 
the internal capsules, was only found in the left hemisphere. Thus, although the overall locations 
of the cyclothymia associations were compatible with the TBSS results, being in fronto-temporal 
and fronto-thalamic connections, there were differences in laterality. Whilst the ATR connects 
the frontal lobes to the thalamus and the striatum, the UF and AF are the two main fronto-
temporal fibre tracts. As reviewed in Chapter 1, these connections are assumed to play key roles 
in emotion perception and regulation according to various neuro-cognitive and neurobiological 
models, and they have been widely associated with BD in brain imaging studies. Our findings 
can be integrated into the models of emotion regulation of Phillips et al. (2003a, 2003b, 2008), 
Strakowski et al. (2005) and Ochsner and Gross (2005): genetic predisposition to BD may 
become manifest through subtle reductions in overall white matter integrity, making unaffected 
relatives more vulnerable to more localised disruptions in emotional brain networks. The latter 
localized disruptions can result from genetic factors or environmental stressors, and may 
correspond to the associations of cyclothymia with FA in parts of the prefrontal-thalamic-limbic 
network I present here. However, the literature does not imply any differences in laterality, 
although a few studies have found that reductions in white matter (Bruno et al., 2008; McIntosh, 
Muñoz Maniega, Lymer et al., 2008), and temporal lobe volumes (Hallahan et al., 2010) of 
affected individuals are stronger in the left hemisphere. The present laterality inconsistency 
between TBSS and tractography may also have a methodological source. Both the left ATR and 
the left UF were decidedly more difficult to trace than their right counterparts and the resulting 
unilateral exclusions of some individuals may have caused a bias towards either hemisphere. 
 
 3.4.3 Limitations 
Given the inconsistencies in previous reports, and the fact that both groups in our study consisted 
of healthy individuals only, we anticipated that any between-group differences would be subtle. 
We therefore maximized the sensitivity of our analyses using high resolution DTI data in 64 
gradient directions in a large well-matched sample of unaffected relatives and controls. 




specific hypotheses, and used state-of-the art methods including TBSS and probabilistic 
tractography. But of course there are a several limitations to this investigation. Firstly, since there 
was no affected patient group in our study, I could not directly assess whether unaffected 
relatives were intermediate between patients and controls with respect to FA, although the 
existing literature indicates that this is the case (Chaddock et al., 2009). Secondly, it is not 
possible to distinguish between genetic effects and the environmental consequences of growing 
up in proximity to someone with major mental illness. However, since white matter integrity is 
under strong genetic control (Konrad et al., 2009; Winterer et al., 2008; Sprooten et al., 2009; 
Chiang et al., 2009; Kochunov et al., 2010), it is likely that genetic factors are the strongest 
determinant of the current findings. Thirdly, tractography of all tracts was not successful for all 
individuals and after visual evaluation of the segmentations, a substantial number of individuals 
were excluded for some of the tracts, particularly the left UF and ATR. We cannot tell from this 
analysis whether these exclusions were random of whether this may have introduced a selection 
bias, as we do not know the true FA values of the discarded tracts, however it is reassuring that 
the numbers of exclusions per tract did not differ between the groups. Finally, in the absence of 
any clear pre-hypothesised regions and following from the widespread results of the voxel-wise 
analysis, it was necessary to exploring the effects of genetic risk across 12 tracts of interest using 
tractography. But this comes with a potential type I error inflation, for which there are no 
standard ways of correcting. Both genetic and cyclothymia effects on the bilateral AF 
comfortably survive a conservative Bonferroni correction, but the more modest effects and 
trends in the genu, ATR and UF do not and need to be interpreted with caution. 
 
3.4.4. Conclusions 
By taking advantage of the high sensitivity of DTI to white matter integrity in combination with 
state of the art methodology, we were able to demonstrate white matter integrity reductions in a 
large sample of unaffected relatives of patients with BD for the first time. Whilst the effects of 
genetic risk were widespread, the associations with cyclothymia were more localized to fronto-
temporal and prefrontal-thalamic connections. This suggests that reduced fronto-temporal and 
fronto-thalamic white matter integrity is a structural substrate of mood instability in both healthy 
controls and unaffected relatives at high genetic risk for BD. Given that white matter integrity as 




unaffected relatives support the consideration of white matter integrity as an endophenotype for 











The protein NRG1 is a trophic factor which directly activates ErbB4 receptor kinases. Both 
NRG1 and ErbB4 have many isoforms, which in combination can serve a multitude of distinct 
functions. Their genes are abundantly expressed in the brain, and have spatially and temporally 
controlled expression profiles. The gene NRG1 is located on chromosome 8 (at 8p12), a genomic 
region historically linked to psychiatric disorders (Tabarés-Seisdedos et al., 2009). The gene for 
ErbB4 is located at 2q34 and regions nearby in 2q have also been linked to psychiatric disorders 
(e.g. Paunio et al., 2001). Evidence suggestive of the involvement of NRG1 and ErbB4 in genetic 
risk for psychiatric phenotypes comes from several angles of research including statistical 
evidence from association studies, but perhaps even more compelling, evidence of NRG1 / 
ErbB4 function. In this introduction I will summarise evidence from association studies, 
followed by a brief description of what is known about NRG1 and ErbB4 functions in the brain 
and their relationships to white matter. I will then present results of my research relating NRG1 
and ErbB4 genotypes to FA as part of the Bipolar Family Study. 
 
4.1.1 Association studies of NRG1 and ErbB4 
When Stefansson et al. (2002; 2003) identified and replicated the association of schizophrenia 
with a haplotype at the 5’end of the gene, NRG1 became one of the most widely accepted 
candidate genes for psychotic disorders. The core Icelandic at-risk haplotype (“HapICE”) consists 
of 5 SNPs (SNP8NRG221132, rs35753505, SNP8NRG241930, rs6994992, 
SNP8NRG433E1006) and two microsatellites. HapICE, its individual SNPs and overlapping 
haplotypes have since been associated with schizophrenia and BD in various populations 
(Alearts et al., 2009; Corvin et al., 2004; Georghieva et al., 2008; Goes et al., 2009; 




2003; Tang et al., 2004; Li et al., 2004; Prata et al., 2009; Walker et al., 2010; Williams 
et al., 2003). But, as with every candidate gene negative findings also exist (Cassidy et al., 
2006; Lachman et al., 2006; Ikeda et al., 2008; Iwata et al., 2004). Confusingly, several studies 
have associated psychotic disorder with opposite alleles, or different haplotypes (Alearts et 
al.,2009; Bakker et al, 2004; Corvin et al., 2004; Georgieva et al., 2008; Kim, Lee, et al., 2006; 
Lachman et al., 2006; Prata et al., 2009; Thomson et al., 2007). The four meta-analyses on 
NRG1 case-control associations available to date also vary in their conclusions and they all stress 
significant heterogeneity across studies and ethnicities, even within the European population and 
especially for HapICE and for rs35753505 (Gong et al., 2009; Li, Collier & He, 2006; Munafa et 
al., 2006, 2008). A further complicating factor is that most of the commonly associated SNPs are 
functionaly ill-defined and are assumed to exert their effect via linkage disequilibrium and/or 
interactions with one or more other SNPs and genes. Hence, the discrepancies between studies 
could be explained by population differences in linkage disequilibrium structure between tagging 
and functional SNPs, as well as more general interactions with genetic and environmental 
background. It is therefore not surprising that the most convincing association results have arisen 
from confined populations such as the Icelandic sample, and that much larger effect sizes have 
been reported in small studies of individuals at high clinical or genetic risk in which all 
individuals homozygous for the risk alleles at rs6994992 presented with psychotic symptoms 
compared to only 14%-46% of the non-risk carriers (Hall et al., 2006; Keri, Kiss & Kelemen, 
2009). 
 Association studies of ErbB4 with psychiatric disorders are less abundant. Silberberg et al 
(2006), found an association with schizophrenia and 3-SNP haplotype comprised of rs7598440, 
rs83523 and rs707284 (A-G-G). Nicodemus et al. (2006) found two haplotypes in ErbB4 to be 
significantly more common in patients, one of which was replicated in two independent samples 
and overlapped with Silberberg's haplotype albeit with opposite risk alleles. Association with the 
other significant haplotype of that study was later replicated in a Han Chinese sample in addition 
to an association with one of the SNPs within it (Lu et al., 2010). Yet others have found no 
(Shiota et al., 2008) or only marginal evidence for association with schizophrenia (Norton et al., 
2006) but instead they found significant interactions with NRG1 genotypes. 
None of the SNPs in HapICE or the Silberberg ErbB4 haplotypes are exonic. Nevertheless, at least 




genes. In post-mortem studies, Law et al. (2006a, 2006b) found that the NRG1 SNP rs6994992 
and each of the SNPs in Silberberg ErbB4 haplotype are associated with mRNA expression 
levels of their respective genes. Furthermore, NRG1 expression is increased in the hippocampus 
of bipolar and schizophrenia patients who have different concentrations of the distinct ErbB4 
mRNA isoforms (Law et al., 2006b; Silberberg et al. 2006). 
 
4.1.2 Functions of NRG1-ErbB4 signalling 
Both NRG1 and ErbB4 produce a large multitude of isoforms by alternative RNA splicing and 
cleavage, the combinations of which define their distinct functions. There is a wealth of in vitro, 
post-mortem and animal research describing the functions of NRG1-ErbB4 signalling. It is 
beyond the scope of this chapter to describe these studies but for reviews see Harrison & Law 
(2006), Mei & Xiong (2008) and Corfas et al. (2004). In general, NRG1 and ErbB4  play 
important roles in neurodevelopmental processes such as neuronal and glial proliferation, 
differentiation and migration as well as axon guidance (Anton et al., 1997; Rio et al., 1997; 
Lopez-Bendito et al., 2006). NRG1-ErbB4 signalling is also vital for many plasticity-related 
processes continuing throughout adulthood such as regulation of NMDA and GABA receptor 
function (Hahn et al., 2006; Gu et al., 2005) and neuron-glia signalling to promote myelination 
(Chen et al., 2006; Taveggia et al., 2008). Many of these processes are akin to key hypotheses of 
schizophrenia: the glutamate hypothesis (Konradi & Heckers, 2003), dysconnectivity hypothesis 
(Friston 1995, 2002; Stephan, Friston & Frith, 2009), GABA-ergic dysfunction (Blum & Mann, 
2002), thereby further supporting NRG1 and ErbB4 as candidate genes. Interestingly for the 
present research, disruption of most of the above processes would have a direct impact on white 
matter structure. 
A few imaging genetics studies indeed found evidence for associations of NRG1 and ErbB4 with 
white matter integrity. Our group have found that healthy individuals homozygous for the risk-
allele ('T') at rs6994992 had reduced white matter density (derived from T1-weighted images) 
and FA in the ALIC (McIntosh, Moorhead et al., 2008), which was later confirmed to be in the 
ATR using tractography (Sprooten et al., 2009). In line with this, Winterer et al. (2008) reported 
reduced medial prefrontal FA in carriers of the C-allele at rs35753505. Similarly, with respect to 




region. In particular, Konrad et al. (2008) found reduced FA in the left temporal white matter, 
including the external capsule in healthy individuals homozygous for the risk-allele ('G') at 
rs839523; whilst Zuliani et al. (2011) found an association of FA in the ALIC, in particular the 
left, in with rs4673628, the locus previously interacting with HapICE on risk for schizophrenia 
(Norton et al., 2008). 
In summary, numerous association studies support the involvement of NRG1 and ErbB4 in 
psychiatric disorders, but there is notorious disagreement about the genomic locations and the 
directions of the risk variants, especially concerning HapICE in NRG1. This suggests a 
complicated picture in which genetic background and environmental factors modulate or mediate 
the effects of genetic variation at the NRG1 and ErbB4 regions. Using intermediate phenotypes is 
one way to reduce the number of environmental factors that may affect clinical phenotypes, and 
considering the functions of NRG1-ErbB4 signalling white matter integrity seems a logical 
mediator between gene and  symptomatology. In this chapter I present an investigation of the 
relationship of FA with four NRG1 SNPs in HapICE and with the three ErbB4 SNPs that make up 
the haplotype identified by Silberberg et al. (2006). 
 
4.2 Methods 
4.2.1 Study sample   
Participants were recruited as part of the Bipolar Family Study. All scanning, genotyping and 
screening were performed as described in Chapter 2. DTI and NRG1 / ErbB4 genotype data were 
available for 196 participants, of which 26 were excluded because they had a first or second 
degree relative who also participated in the study. These excluded participants were selected at 
random for each family. After this, 170 individuals were left, including 87 unaffected relatives of 
patients with BD. 
 
4.2.2 Genotyping and haplotype estimation 
Seven SNPs were genotyped: four SNPs in the NRG1 region (NRG221132, rs35753505, 




rs707284). For all SNPs, allele frequency distributions were in accordance with the Hardy-
Weinberg equilibrium although one SNP, rs6994992, had a p-value of 0.09. As expected, SNPs 
within haplotypes were in high linkage disequilibrium with each other. See Table 4.1 for 
genotype distributions and Table 4.2 for allele frequencies and for statistics of Hardy-Weinberg 
equilibrium tests and linkage disequilibrium. Haplotypes were estimated using PLINK 
(http://pngu.mgh.harvard.edu/~purcell/plink/), which applies an expectation–maximization 
algorithm. The 4 SNP NRG1 core Icelandic risk haplotype was identified as ‘GGCT’ at 
NRG221132, rs35753505, NRG241930, and rs6994992 respectively. The 3 SNP haplotype as 
identified by Silberberg et al. (2006) and Law et al. (2007) is ‘TCC’ at rs7598440, rs839523 and 
rs707284, respectively. Both risk haplotypes were common in our sample with frequencies of 
0.36 for HapICE and 0.58 for the ErbB4 haplotype. Haplotype estimation was successful for all 
participants with most posterior probabilities equal to 1, and all exceeding 0.78. 
In our sample, there was an association of the rs6994992 NRG1 SNP with at-risk status (χ
2
 = 
4.091, p = 0.043), where the minor allele (“C”) was less common in the high risk group than in 
the control group. Other allele frequencies had similar frequencies in both groups (all p > 0.14). 
Neither haplotype frequency was significantly higher in the unaffected relatives (HapICE: p = 
0.13; HapErbB4: p = 0.87). For NRG221132 only 3 individuals were homozygous for the A-allele, 
so they were combined with the heterozygotes into an A-carrier group. IQ differed significantly 
between the NRG1 haplotype and SNP groups in the healthy control group (all p < 0.05). There 
was also some statistical dependence of sex with the HapICE in the controls (χ
2 
= 5.918, p = 
0.052); and with rs35753505, rs6994992 and HapICE in the unaffected relatives (χ
2
 = 8.669, p = 
0.034; χ
2
 = 6.597, p = 0.06; χ
2
 = 4.968, p = 0.088; respectively). Potential confounding effects of 
these demographic measures were examined in post-hoc analyses. Age did not differ between the 
NRG1 genotype groups (p > 0.42). All ErbB4 genotypes were well-matched for age, IQ and sex 
(all p > 0.18). 
 
4.2.3 TBSS and tractography 
TBSS was performed according to standard procedures available from FSL and as described in 
detail in Chapter 2. Average FA over the whole skeleton was also extracted, and ANOVA's were 
performed in SPSS to test any effects of genotypes on this summary measure. For its increased 




NRG1 and ErbB4 haplotypes, and for interactions with age. Age is of special concern in the case 
of NRG1-ErbB4 signalling because of their temporally controlled expression profile and its 
 
 
Table 4.1. Number of participants per genotype 
SNP / Haplotype HC (N = 83)* HR (N = 87)* HWE (p) 
HapICE (0 – 1 - 2) 30 – 38 - 15 39 – 33 – 15 - 
rs35753505 (AA-AG-GG) 29 – 37 - 14 37 – 33 - 14 0.24 
rs6994992 (CC-CT-TT) 27 – 36 - 20 35 – 35 - 15 0.09 
NRG221132 (AA-AG-GG) 1 – 17 - 65 2 – 16 – 69 1 
NRG241930 (AA-AC-CC) 11 – 37 - 35 13 – 37 - 37 0.24 
HapErbB4 (0 – 1 - 2) 15 – 40 - 28 13 – 49 - 25 - 
rs707284 (CC-CT-TT) 40 – 35 - 8 45 – 35 – 7 0.74 
rs7598440 (CC-CT-TT) 14 – 40 - 28 12 – 50 – 25 0.58 
rs839523 (CC-CT-TT) 44 – 32 - 7 48 – 33 – 6 0.72 
*There are a few missing values, due to undetermined genotypes 
 
Table 4.2: SNP-by-SNP linkage disequilibria 
 Linkage Disequilibrium (D’) 
NRG1 NRG221132 rs35753505 NRG241930 rs6994992 
NRG221132 1    
rs35753505 1.000 1   
NRG241930 1.000 0.976 1  
rs6994992 1.000 0. 943 1.000 1 
ErbB4 rs7598440 rs839523 rs707284  
rs7598440 1    
rs839523 0.980 1   






involvement in brain development. Indeed, different patterns of grey matter development have 
been found in children carrying NRG1 risk-alleles (Addington et al., 2007). 
Probabilistic neighbourhood tractography was performed as described in Chapter 2. Visual 
inspection of the tract segmentations led to the exclusion of a significant number of people for 
deviations of known anatomy of some of the tracts. These exclusions were done on a tract-by-
tract basis, and the application of mixed models allows for appropriate within-subject analyses 
with missing data for one hemisphere but not for the other. As discussed in Chapter 2, the left UF 
and ATR in particular proved difficult to trace. For the left UF, 26 unaffected relatives and 14 
controls were excluded, whilst for the left ATR 15 unaffected relatives and 11 healthy controls 
were excluded. Seven individuals were excluded for the right AF. Exclusions for the other tracts 
were minimal ranging from 1 to 3 individuals. 
 
4.2.4 Multiple testing and corrections 
Inflation of type I error due to multiple testing should be considered for several factors, namely 
tests across many voxels in TBSS, tests across multiple tracts and hemispheres and tests across 
multiple SNPs and haplotypes. TFCE of course corrects for multiple testing across voxels. All 
reported p-values resulting from the TBSS analysis were corrected in this fashion. For each SNP, 
two genetic models were tested, a dominant model (risk-carriers vs. non-risk homozygotes), and 
a recessive model (risk-homozygotes vs. non-risk carriers). Because both homozygotes remain in 
the same group, these models are also statistically dependent. No correction was performed for 
this, but results were examined to see if they were in agreement with one another. To the extent 
one considers these tests independent, a higher agreement between the two results implies a 
lower probability of a false positive. 
For the 2 haplotypes and 7 SNPs, traditional Bonferroni corrections would be overly 
conservative since the SNPs and haplotypes within each gene are in extremely high linkage 
disequilibrium (Table 4.1). Dividing the p-value threshold by a factor of two (for the separate 
genes) would be more appropriate, albeit arguably somewhat anti-conservative. I will consider 




FA values are also highly correlated across tracts (Penke et al., 2010), again making a Bonferroni 
correction overly conservative. Hence, for initial detection of significant effects the reported p-
values are uncorrected. Especially for interaction terms which have less statistical power it 
would be important to keep type II error low. Similar to Chapter 3, after analyses, any significant 
p-values are compared to Bonferroni corrected significance thresholds which were computed for 
each result separately depending on the number of tests performed to obtain it. Thus, the initial 
alpha 0.05 is first divided by the number of mixed models performed, one for each tract, i.e. 5 
unilateral + 2 corpus callosum = 7 tracts. If any interaction was observed and two subsequent 
tests were performed to examine effects within group or hemisphere, the resulting significant 
threshold was further divided by 2 (either hemispheres or group) or 4 (if it concerns a unilateral 
effect within one group). However, it should be borne in mind that this remains a conservative 





In the healthy control group, individuals homozygous for the risk-alleles at NRG241930, 
rs35753505, and at rs6994992 had significantly increased FA in several frontal white matter 
areas, most prominently in the ATR (pFWE < 0.05). Other regions less consistently associated with 
genotype across NRG1 SNPs were the fornix / stria terminalis, external capsules, brain stem, left 
cerebellar peduncle, temporal lobes bilaterally, and left temporo-parietal white matter (pFWE < 
0.05). Figure 4.1 shows the significant effect of rs35753505 on FA in all of these regions. 
Corrected p-maps for NRG241930 were very similar, while for rs6994992 significant results 
were confined to the bilateral ATRs, the brainstem and the left temporal lobe. The same areas 
showed a trend for increased FA in individuals carrying two risk-haplotypes compared to 
heterozygotes and non-risk carriers combined, with family pFWE between 0.06 and 0.10. 
In the high risk group there were no significant effects for any SNP, nor for the NRG1 core 
haplotype. There was a trend for decreased FA in the splenium of the corpus callosum in 




The above findings, as well as Figure 4.1, suggest NRG1 genotypes have a different effect in the 
controls than in the high risk group. However, voxel-wise F-tests were not significant for 
genotype-by-group interactions (all p > 0.99). TFCE-based F-tests in FSL have appeared to be 
very conservative in other instances
1
, where they produced corrected p-values pFWE > 0.99 whilst 
T-tests of the same ‘randomise’ contrasts produced corrected p-values at trend-levels (pFWE < 
0.08). Unsurprisingly, group-by-genotype interactions were highly significant on the extracted 
FA averages within the significant clusters (all F between 6.06 and 12.47, all p < 0.003). 
 
Figure 4.1.  The effects of NRG1 SNP rs35743505 on FA in the control group, obtained using 
TBSS (pFWE < 0.05). Note that the bar graph is added to illustrate the directions of effects of the 
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Figure 4.2. Effects of age on the association between NRG1 SNP rs35743505 and FA. The “risk-
allele” originally reported in Stefansson et al. (2002) was “G”.  
Genotype key: “A”=AA; “Both”=AG; “G”=GG 
 
 
None of the SNPs had a significant effect on the extracted whole-skeleton FA, although there 
was a trend for rs35743505 in the control group (F = 2.493, p = 0.089). For HapICE, however, 
there was a HapICE-by-group interaction on whole-skeleton FA (F = 5.793, p = 0.017), which was 
driven by significantly increased FA in the controls homozygous for the risk-haplotype (F = 
4.669, p = 0.034) whilst unaffected relatives homozygous for the risk-haplotype had on average 
lower whole-skeleton FA than the non-risk carriers, albeit non-significantly so (F = 1.724, p = 
0.193). 
Post-hoc analyses of the cluster averages including sex and IQ in the model (since they were 
differently distributed across NRG1 genotype groups) all resulted in genotype effects of p < 
0.001, indicating that the above results were not caused by differences in sex or IQ. The 
genotype groups were well-matched for age, but there was a significant age-by-genotype 
interaction for rs35753505 on average FA from the skeleton (F = 5.374, p = 0.006, Figure 4.2). A 
similar effect was found for rs6994992-by-age interactions (F = 2.861, p = 0.015). For both 




inconsistently) reported to be the non-risk or protective allele, FA is negatively associated with 
age, while in others FA increases with age as would be expected in young people. Note, however, 
that these data are cross-sectional, as is further discussed in the next section. 
Considering the multiple testing corrected p-value for testing two genes, only the contrast 
comparing A carriers to G homozygotes at rs35743505 contained voxels significant at pFWE < 




In keeping with the TBSS analysis, tractography revealed several significant effects of NRG1 
genotypes on FA. Individuals carrying two copies of the NRG1 core risk haplotype had 
significantly higher FA in the bilateral ATRs (F = 4.525; p = 0.012) compared to the other two 
groups. This was also the case for the bilateral UFs in the healthy control group (F = 4.311, p = 
0.017), but not in the high risk group (F = 0.324, p = 0.724; group-by-haplotype interaction: F = 
3.157, p = 0.045). A similar pattern was seen for the SNP rs35753505: in the bilateral ATRs the 
risk allele was associated with increased FA across both groups (F = 4.590, p = 0.012) and in the 
bilateral UFs this was only the case in the healthy control group (F = 4.089, p = 0.021; group-by-
genotype interaction: F = 3.338, p = 0.038). Again, for rs6994992 the same pattern occurred in 
the ATR, bilaterally, across both groups (F = 4.657, p = 0.011). Although there were no group-
by-genotype interactions on FA in the ATR (all p > 0.20), the association was much stronger in 
the control group (HapICE: p = 0.002; rs35753505: p = 0.001; rs6994992: p = 0.008). These 
results in the ATR and UF are illustrated by Figure 4.3 and Table 4.3, and Figure 4.4 and Table 
4.4, respectively. 
Post-hoc analyses including IQ and sex in the mixed models indicated that none of these 
significant effects were caused by confounding of IQ or sex. In fact, the effects of NRG1 
haplotypes and rs35753505 genotypes on the UF in the control group became dramatically more 
significant at p = 0.002 and p = 0.001, whilst all the above genotype effects on FA in the ATR 
across both groups remained significant at p = 0.030. Whilst the main effect of rs35743505 in the 
ATR would not survive the most stringent multiple comparison corrections at p < 0.0071 (0.05 / 




* 2]). The IQ-corrected effects in the UF in the controls are also below this corrected threshold at 
p < 0.0036. And more restrictively, only the effect of rs35743505 in the ATR in the control group 
(p = 0.001) would survive yet another correction of testing two genes (0.05 / [7 * 2 * 2]). There 
were no significant results for the genu, splenium, AF, CST or cingulum. There were also no 




Using TBSS, we did not detect any effects of ErbB4 SNPs that were significant on the whole-
brain level, neither in the control sample (all pFWE > 0.11) nor the high risk sample (all p > 0.30). 
Similarly, there were no effects of the ErbB4 haplotype on the whole-brain level in the control 
group (all p > 0.17), or in the high risk group (all pFWE > 0.35). The same was true for the 
combined sample, in which T-tests and F-tests in ‘randomise’, whilst co-varying for group, were 
all non-significant on the whole-brain level (all pFWE > 0.31). There were also no significant 
group-by-genotype interactions detected by the F-test in the large model of combined groups 
(pFWE > 0.64). 
There were also no significant effects of ErbB4 on whole-skeleton FA, and importantly, no 
significant interactions between NRG1 and ErbB4 on whole-skeleton FA. 
 
4.3.2.2. Tractography 
Compared to NRG1, the effects of ErbB4 on FA, if any, were less clear. Overall, significant 
effects were confined to the CST and the cingulum. In the cingulum, there was a significant 
interaction between rs707284 and group (F = 3.298, p = 0.039), driven by a significant effect of 
rs707284 on the bilateral cingulum in the control group (F = 3.192, p = 0.046), but not in the 
high risk group (F = 0.712, p = 0.494). In this tract, similar trends were observed for the ErbB4 
core haplotype (interaction: F = 2.310, p = 0.103; within control group: F = 3.408, p = 0.038) 
and for rs7598440 (interaction: F = 2.986, p = 0053; within control group: F = 2.931, p = 0.056). 




Figure 4.3. Effects of NRG1 on FA in the ATR, separated for group and hemisphere. Effects are shown  for 
HapICE, and two SNPs within HapICE: rs35753505 (risk-allele “G”) and rs6994992 (Risk allele “T”). 
Significant effects of genotype on FA were found for all three genetic markers, across hemispheres.  
“A”=AA; “G”=GG; “C”=CC; “T”=TT; “Both”= heterozygous. 
 
Table 4.3. Summary of simple effects of HAPICE  on FA in the ATR,  separated per group 
HAPICE 
Mean (SD) Statistics 
0 1 2 F p df η^2 
HC               
left 0.3700 (0.0217) 0.3758 (0.0309) 0.3929 (0.0302) 3.239 0.043 70 0.085 
right 0.3721 (0.0312) 0.3856 (0.0332) 0.4017 (0.0278) 4.525 0.014 80 0.101 
HR               
left 0.3672 (0.0312) 0.3647 (0.0438) 0.3853 (0.0248) 1.475 0.236 73 0.040 
right 0.3874 (0.0325) 0.3788 (0.0419) 0.3916 (0.0326) 0.810 0.448 82 0.018 
Note that the main analyses were not performed on simple effects per unilateral tract, but as mixed regressions, 
across hemispheres (and tracts). This table is included to provide meaningful effect sizes that allow for compari-
sons across studies, not for assessing the statistical significance of the present findings per se. The values corre-
spond to those illustrated in Figure 4.3. df = degrees of freedom; η^2 (eta squared) = effect size as proportion of 




Figure 4.4. Effects of NRG1 on FA in the UF, separated for group and hemisphere. Effects are shown  for 
HapICE, and two SNPs within HapICE: rs35753505 (risk-allele “G”)and rs6994992 (Risk allele “T”). Significant 
effects of genotype on FA were found for HapICE  and rs35753505 across hemispheres, in the control 
group only. “A”=AA; “G”=GG; “C”=CC; “T”=TT; “Both”= heterozygous. 
 
Table 4.4. Summary of simple effects of HAPICE  on FA in the UF,  separated per group 
HAPICE 
Mean (SD) Statistics 
0 1 2 F p df η^2 
HC               
left 0.4111 (0.0297) 0.4261 (0.0317) 0.4365 (0.0341) 3.215 0.046 68 0.082 
right 0.4209 (0.0304) 0.4270 (0.0335) 0.4431 (0.0311) 2.435 0.094 80 0.061 
HR               
left  0.4096 (0.0282) 0.4146 (0.0320) 0.4017 (0.0472) 0.522 0.569 62 0.015 
right 0.4259 (0.0359) 0.4135 (0.0374) 0.4219 (0.0323) 1.06 0.351 83 0.027 
Note that the main analyses were not performed on simple effects per unilateral tract, but as mixed regressions, 
across hemispheres (and tracts). This table is included to provide meaningful effect sizes that allow for compari-
sons across studies, not for assessing the statistical significance of the present findings per se. The values corre-
spond to those illustrated in Figure 4.4. df = degrees of freedom; η^2 (eta squared) = effect size as proportion of 





Figure 4.5 Effects of ErbB4 genotypes on FA in the cingulum, separated for group and hemisphere. Effects 
are shown for the ErbB4 haplotype and two SNPs within the haplotype: rs707284 (risk-allele “C) and 
rs7598440 (risk-allele “T”). Significant effects were found for the haplotype and genotype at rs707284, 









Figure 4.6. Effects of ErbB4 genotypes on FA in the CST, separated for group and hemisphere. Significant 
hemisphere-by-genotype interactions were found for the Haplotype and genotypes at rs707284 and 












In the CST, on the other hand, there were hemisphere-by-genotype interactions for the ErbB4 
haplotype (F = 3.653, p = 0.028), rs707284 (F = 4.453, p = 0.013) and rs7598440 (F = 3.516, p = 
0.032). However, what may have driven this interaction is not entirely clear. For both SNPs and 
the ErbB4 haplotype, there were merely trends for genotype effects in the left CST (p < 0.10) 
with no trends in the right hemisphere. Looking at Figure 4.6, it may also be caused by 
essentially a 3-way group*genotype*hemisphere interaction, but breaking down the analyses for 
groups, hemispheres and genotype groups may have left too little power to detect subtle 3-way 
interactions. Also, it should be noted that the distribution of FA in the CST deviates from 
normality. Although mixed-effects models, as regressions, are fairly robust against deviations of 
normality, strange observations may occur because of extreme violations of the normality 
assumption. None of the effects of ErbB4 genotypes survives our Bonferroni corrected p-values. 




Here, I present an investigation of white matter integrity in relation to NRG1 and ErbB4. Genetic 
variation in NRG1 was associated with FA in the bilateral ATR and  UF. These are the same two 
regions as found previously in similar analyses of both NRG1 and ErbB4 genotype effects in 
healthy individuals (Konrad et al., 2009; McIntosh, Moorhead et al., 2008; Sprooten et al., 2009; 
Winterer et al., 2008; Zuliani et al., 2011). The clearest effects were observed in the control 
group, with in the unaffected relatives weaker effects of NRG1 variants on the ATR and no 
effects on the UF. From the present study, the effects of ErbB4 on FA are inconclusive, with 
some weak evidence for interactions with genetic background in the CST and the cingulum, 
regions not highlighted in previous studies. 
 
4.4.1 Risk variants in NRG1 and ErbB4 are associated with increased FA in the ATR and UF 
As noted in Chapter 1, the ATR and the UF, connecting the prefrontal cortex to the thalamus and 
the medial temporal lobe respectively, are assumed to be central to emotion regulation and BD 




Chiang, McMahon et al., 2011; Kochunov et al., 2010) and is also associated with genetic 
liability to psychosis (McIntosh et al., 2006; Sprooten et al., 2011; also see Chapter 3). Whilst 
the locations of the effect of NRG1 genotypes were entirely in line with what would be expected, 
the direction of the effect was not: the risk-alleles and risk-haplotype were consistently 
associated with increased FA, thus contradicting all previous studies of white matter and NRG1 / 
ErbB4 (Konrad et al., 2009; McIntosh, Moorhead et al., 2008; Sprooten et al., 2009; Winterer et 
al., 2008; Zuliani et al., 2011). Although contradictory, it is not completely out of line with the 
background literature and there are several possible explanations for this finding. First, as 
mentioned in the introduction, there is disagreement on the definition of the “risk-alleles” at 
NRG1 loci, with high heterogeneity between studies and populations, especially for rs35753505 
and HapICE. Although the Icelandic risk-allele finding at rs35753505 was initially replicated in a 
Scottish sample (Stefansson et al., 2003), a subsequent Scottish association study found the 
opposite allele to be associated with increased risk (Thomson et al., 2007). A series of studies in 
other populations also associated these “opposite” alleles at rs35753505 and/or rs6994992 with 
increased risk (Alearts et al., 2009; Georgieva et al., 2008; Kim, Lee et al., 2006; Prata et al., 
2009). Interestingly, I found a marginally significant association of risk-status with the C-allele 
at rs6994992 in our own sample, which is again the opposite allele initially indentified as the 
risk-allele in the Icelandic study. Since affected individuals were excluded from our at-risk 
sample, this could imply a protective genetic effect of this allele, but considering most people in 
our sample are younger than the typical age of onset for psychosis it more likely reflects 
population heterogeneity. Different linkage disequilibrium patterns surrounding the studied SNPs 
with the more functional SNPs and different genotypes at interacting gene's locations could be 
responsible for what appears to be a paradoxical finding both in the case-control association 
studies cited above and in our own association with white matter integrity. 
Secondly, environmental or demographic factors can also interact with NRG1 genotypes to 
increase or decrease FA, especially since NRG1 is involved in plasticity (Hahn et al., 2006; Gu 
et al., 2005; Mei & Xiong, 2008). Obviously in our young sample, one demographic variable of 
special interest is age. In contrast to our previous sample (McIntosh, Moorhead et al. 2008, 
Sprooten et al. 2009), the present participants were at an age at which white matter, especially in 
limbic and prefrontal areas, continues to develop quite rapidly (Barnea-Goraly et al., 2005; Bava 
et al., 2010; DiGiorgio et al., 2008; Kochunov et al., 2010; Lebel et al., 2008). Furthermore, 




2011) and NRG1 and ErbB4 expression, and the concentrations of their distinct isoforms, also 
changes during development (Mei & Xiong, 2008). NRG1 and ErbB4 genotypes are associated 
with different patterns of grey matter development in children (Addington et al. 2007), and I also 
found some evidence for an age-by-genotype interaction on FA (with rs35743505). Together, 
these pieces of information imply complex interactions between NRG1, white matter 
development and age, and further longitudinal studies incorporating a wider age range, will be 
necessary to disentangle these. 
Since NRG1 directly binds to ErbB4 via the epidermal growth factor domain, epistasis between 
NRG1 and ErbB4 genotypes on FA are plausible. NRG1-by-ErbB4 interactions would perhaps be 
the most compelling explanation for our inconclusive findings for ErbB4 combined with the 
counterintuitive direction of effect for NRG1. And indeed, two studies report such epistasis on 
risk of schizophrenia (Norton et al., 2006; Shiota et al., 2008), although Addington et al. (2007) 
failed to find support for epistasis on grey matter development. Similarly, in the present analyses 
we could not find any interactions between NRG1 and ErbB4 on whole-skeleton FA. However, 
technically our numbers within ErbB4/NRG1 genotype cells are too small to interpret a negative 
finding, especially, since the most interesting contrast in our results requires splitting up the 
homozygous NRG1 risk group, which is the smallest (N = 15), along ErbB4 genotypes. I also did 
not test ErbB4 / NRG1 interactions in the voxel-wise analyses because that would require even 
larger samples. 
 
4.4.2. Effects of NRG1 and ErbB4 are more pronounced in the control group 
The present results are more pronounced in the control group, and each effect is more or less 
absent in the unaffected relatives. This is contrary to the idea that candidate genes might have 
more pronounced effects against a vulnerable genetic background, but there are several possible 
explanations for why we failed to observe such increased sensitivity in the high risk group. 
Individuals at high genetic risk already have widespread FA reductions (Chapter 3; Sprooten et 
al., 2011), and so we may be looking at a “floor effect”, in the sense that when white matter 
integrity is already reduced it becomes more resistant to any further reductions. Sampling bias 
may also have contributed to this, because further reductions may have behavioural or clinical 




been excluded from our study. In addition, the high risk group may be more heterogeneous as a 
sample. During brain development a great multitude of interacting genetic and environmental 
variables impact upon brain structure and these may have a broader range in individuals of 
affected families. The complexity of these interactions and the wide variety of environmental 
circumstances can obscure subtle effects of single genes on brain structure, let alone single SNPs 
or haplotypes. A third explanation comes from looking at the data in the high risk subjects, where 
a pattern emerges of heterozygous individuals having the lowest FA. This implies a possible 
interaction of the biological mechanisms of NRG1 on the molecular level with genetic 
background. The mechanisms of such interactions remain open to speculation, but may involve a 




A first limitation, as is the case in other chapters, is that tractography was not always successful 
leading to the exclusion of a number of participants for some tracts, especially for the left ATR 
and the left UF. It is unclear whether these exclusions are random since the real FA within these 
tracts cannot be known. But it is encouraging that the TBSS and tractography results are 
compatible with one another. Perhaps the most important limitation is the multiple tests that were 
performed. As mentioned in the methods section, the probability of false positives is not simply 
the number of tests times the p-values since neither FA across tracts, nor SNPs are independent 
measures. In the TBSS analyses, only one contrast of one SNP would survive a liberally 
corrected p-value (i.e. only divided by the number of genes). In the tractography analysis, the 
effects of NRG1 on the ATR and the UF in the control group were significant at a post-hoc 
Bonferroni corrected p-value, but none of the ErbB4 effects were. It should also be borne in 
mind that the ATR would have been the top-ranked a priori region given our previous studies 
(McIntosh, Moorhead et al., 2008; Sprooten et al., 2009; Zuliani et al., 2011), and the 
consistency between TBSS and tractography methods further reduces the possibility of false 
positives. Nevertheless, in isolation the associations we found between NRG1 and FA should be 
treated with caution, and it is only in integrating them with previous findings and by observing 
their consistency, that we can be more confident of the association of NRG1 with white matter 




the observation that for both genes the haplotypes appeared less sensitive to FA differences than 
the SNPs. Given the heterogeneity at the NRG1 locus, as observed by all four meta-analyses 
(Gong et al., 2009; Li, Collier & He, 2006; Munafa et al., 2006, 2008), it may mean that the 
particular NRG1 and ErbB4 haplotypes are not appropriate in our population for either white 
matter or clinical phenotypes. Ideally, sample-specific determination of haplotypes by 




In our sample of young healthy individuals I found modest associations of NRG1 with white 
matter integrity in frontal and temporal fibres. Whether ErbB4 genotypes also influence white 
matter integrity remains unclear. In unaffected relatives of patients with BD we could also not 
detect any clear associations. Integrating these findings with the available literature, it seems that 
NRG1-ErbB4 signalling has an impact on many neurodevelopmental processes including white 











5.1.1  Evidence for the involvement of DISC1 in psychiatric disorders 
More than two decades ago St Clair et al. (1990) discovered a remarkable co-segregation of a 
genetic mutation with schizophrenia and affective disorders in a large Scottish family. In this 
family 29 of the 37 people who inherited a translocation between chromosomes 1 and 11, 
developed schizophrenia, BD or major depression, whilst none of the 38 relatives with normal 
karyotypes were diagnosed with a major psychiatric disorder (Blackwood et al., 2001). With log 
odds ratios of 3.6 with schizophrenia and 7.1 with the broader psychiatric phenotype, this co-
segregation was highly significant in this family, and inspired a wealth of research during the 
following decades. 
Muir et al. (1995) identified the breakpoints of the translocation at 1q42 on chromosome 1 and 
11q14 on chromosome 11. Sequencing of the breakpoint region on chromosome 1 revealed that 
two genes were disrupted by the 1:11 translocation: “disrupted in schizophrenia 1” (DISC1) on 
the anti-sense strand and “disrupted in schizophrenia 2” (DISC2) on the sense strand (Millar et 
al., 2000). Since DISC1 is on the anti-sense strand, it is the gene responsible for encoding the 
protein DISC1, whereas DISC2 may be involved in the regulation of DISC1 expression but not in 
protein translation itself. Recently a gene disrupted by the breakpoint on chromosome 11, DISC1 
Fusion Partner 1 (DISC1FP1) has also been identified, but due to its recent discovery very little 
research has been conducted on its function so far (Zhou et al., 2008). DISC1 is the main focus 
of this chapter, as it remains the most likely causal gene of the psychiatric phenotype in the 1:11 
family to this date. 
Family studies are useful for the identification of rare genetic variants and mutations that may 
convey a substantial increase in risk for a clinical phenotype. On the other hand, a finding in one 




family, and not provide insight into the causes of the disorder in the general population. Hence, 
association and linkage studies in other samples were conducted to confirm the link between the 
DISC1 gene and psychiatric phenotypes. Although no study has reported an effect (i.e. odds ratio) 
of genetic variation in DISC1 as strong as in the original 1:11 family, linkage and association 
studies of DISC1 SNPs and haplotypes outside the 1:11 family have provided independent 
evidence for the involvement of common DISC1 variants in psychiatric disorders in a wide 
variety of populations including Finnish, North American, Chinese and various Asian 
populations (reviewed in Chubb et al., 2008). A recent study combined data from the four 
European association studies, and identified three SNPs as most significantly associated with BD 
(Hennah et al., 2008). 
 
5.1.2  Functions of DISC1 
Despite a decade of intensive research into DISC1 function, the precise mechanisms by which 
genetic variation in the DISC1 region impacts upon mental health remain to be elucidated. The 
protein DISC1 interacts with a multitude of other proteins and molecular pathways, but so far 
these have converged on several candidate causal mechanisms rather than a single disrupted 
function. DISC1 is abundantly expressed in the brain, most prominently in the hippocampus and 
other limbic regions, and its expression levels vary at different stages of human development 
(Chubb et al., 2008). Evidence from animal studies and cell cultures indicate that DISC1 
regulates several neuro-developmental processes relevant to the aetiology of psychiatric 
disorders including, but not limited to, neuronal proliferation, differentiation and migration 
(Ishizuka et al., 2011; Kamiya et al., 2005; Mao et al., 2009), axon growth (Brandon et al., 2009; 
Hur & Zhou, 2010; Mao et al., 2009) and axon myelination (Wood et al., 2008). Although 
complete DISC1 knockout is impossible in rodents, (partially) mimicking the 1:11 translocation 
or reducing DISC1 expression in transgenic mice can result in several depression- and 
schizophrenia-like deficits in working memory, pre-pulse inhibition, as well as reductions in total 
brain volume, dendritic arborisation and possibly enlarged ventricles (Clapcote et al. 2007; 
Pletnikov et al. 2008). Notably, DISC1 knockdown in zebrafish leads to severe disruption of 
axonal development (Wood et al., 2008). Thus, from the available literature it appears that 
variation in DISC1 increases susceptibility to psychiatric disorders by (directly or indirectly) 




continues to develop during late adolescence and early adulthood (Lebel et al., 2008) compatible 
with the average age of onset of psychotic and affective disorders, making white matter a 
plausible site for the effects of DISC1 and other (genetic and environmental) risk factors to 
converge and impact upon mental wellbeing. 
A complementary approach to animal research and cell culture to gain understanding in gene 
function is to investigate intermediate phenotypes relevant to psychiatric disorders in the human 
brain in vivo. In the original 1:11 family study it was already established that DISC1 has an effect 
on auditory processing in the brain; the P300 ERP peaked later and with lower amplitude in 
carriers of the translocation compared to non-carriers, similar to what is observed in 
schizophrenic patients (Blackwood et al., 2001). Common DISC1 risk-haplotypes and SNPs 
have also been associated with working memory impairments, long-term memory impairments 
and grey matter reductions in the prefrontal and temporal cortices (Burdick et al., 2005; Cannon 
et al., 2005; Carless et al., 2011; Hennah et al, 2005). A recent analysis by our group has shown 
interesting interactions between the three SNPs associated with BD in the combined European 
samples (Hennah et al., 2008) and diagnoses of BD and schizophrenia on BOLD signal in 
various brain areas during a language task (Chakirova et al., 2011). 
One of the few non-synonymous, exonic DISC1 SNPs, rs821616, resulting in a serine to cysteine 
substitution (Ser704Cys), has particularly received a lot of attention in the context of 
intermediate phenotypes. Apart from three studies reporting an association of Ser704Cys with 
schizophrenia, BD and major depression (Callicott et al., 2005; Hashimoto et al., 2006; Qu et al., 
2007), this SNP has been associated with several cognitive performance measures including 
short and long-term memory, logical and abstract reasoning and verbal reasoning skills in the 
elderly (Callicott et al., 2005; Kamiya et al., 2006; Thomson et al. 2005). The latter finding is 
complicated by a distinct sex by genotype interaction, suggesting it is important to examine any 
interactions and between group differences with respect to sex. Using MRI this SNP has been 
associated with hippocampal structure and function, hippocampus–prefrontal functional 
connectivity, and grey matter density in a number of cortical regions including the bilateral 
fusiform gyri, bilateral middle temporal gyri, medial frontal regions, right inferior parietal cortex 
and left precuneus (Callicott et al., 2005; DiGiorgio et al., 2008, Hashimoto et al., 2006). So far, 
evidence for an effect of DISC1 on human white matter integrity is very limited, with only one 




here uncorrected statistical thresholds were used in only a small sample of healthy individuals 
(Hashimoto et al., 2006). Notably, the above intermediate phenotype measures are among the 
most consistently replicated neural and cognitive abnormalities in schizophrenic patients, and to 
a lesser extent in affective disorders (Arnone et al., 2009; Forbes et al., 2009; Hallahan et al., 
2011; Lewandowski et al., 2011; Mcintosh et al., 2005; Stephanopoulou et al., 2009). 
In summary, for its unique translocation and hereditary patterns of psychiatric phenotypes, the 
1:11 family has been tremendously valuable in the discovery of the DISC1 locus. Since then it 
has become clear that genetic variation in the 1q32-42 region is associated with psychiatric 
disorders in the general population. To understand the mechanisms by which genetic variation in 
DISC1 can potentially cause clinical symptoms, DISC1 function needs to be examined on all 
scales, from the sub-molecular to the system level. The prevailing notion at the moment is that 
DISC1 is involved in several neural developmental processes, including neuronal proliferation 
and migration and axon myelination, and that this has various consequences for cognitive 
functioning and the structure and function of the mature human brain. MRI studies have 
previously demonstrated associations between DISC1 genotypes and grey matter density and 
activation in healthy people, however to this point no convincing evidence exist for an 
association with white matter integrity. Using DTI followed by various state-of-the-art analysis 
methods, I investigated in detail whether genetic variation in the common, non-synonymous 
Ser704Cys SNP is associated with white matter integrity in the healthy human brain. 
 
5.2 Methods 
5.2.1 Study sample 
Participants were recruited as part of the Bipolar Family Study, and they were interviewed, 
neuro-psychologically assessed, scanned and genotyped according to the methods described in 
Chapter 2. In cases where participants were genetically related to one another, one person of 
each family was randomly selected to be included in the analysis sample. Demographic 
information of the study sample and DISC1 rs821616 genotype frequencies are summarised in 
Table 5.1. Note that rs821616 is a symmetric SNP, and that in our case the T-allele is the minor 





Table 5.1: Demographic and genotype information of the study sample. 
Control Group AA (N = 39) AT (N = 38) TT (N = 10) statistic (p-value) 
age in years (SD) 20.7 (2.33) 21.1 (2.38) 21.6 (2.82) F = 0.55 (p = 0.58) 
male (%) 17 (44%) 16 (40%) 6 (60%) χ² = 1.07 (p = 0.59) 
handedness (N left handed) 3 2 0 NA 
IQ (SD) 113 (2.11) 111 (2.26) 119 (3.00) F = 1.45 (p = 0.24) 
occupation parent 
(% manual)  
15 (38%) 14 (37%) 3 (33%) χ² = 0.37 (p = 0.83) 
History of substance abuse1         
  nicotine 11 (29%) 10 (26%) 1 (10%) χ² = 1.51 (p = 0.27) 
  alcohol (units / week)2 14 11 7.5 p = 0.851 
  cannabis 26 (67%) 24 (63%) 7 (70%) χ² = 0.21 (p = 0.90) 
  hallucinogens 5 (13%) 8 (21%) 0 (0%) χ² = 3.01 (p = 0.22) 
  stimulants 9 (23%) 10 (26%) 3 (30%) χ² = 0.24 (p = 0.89) 
  sedatives 1 0 0 NA 
High Risk Group AA (N = 41) AT (N = 37) TT (N = 12) statistic (p-value) 
age in years (SD) 21.8 (2.78) 20.8 (2.68) 22.0 (3.05) F = 1.40 (p = 0.25) 
male (%) 19 (46%) 17 (46%) 5 (42%) χ² = 0.09 (p = 0.96) 
handedness (N left handed) 1 4 1 NA 
IQ (SD) 108 (12.94) 103 (15.48) 106 (12.70) F = 0.99 ( p = 0.38) 
occupation parent: manual 
(%) 
18 (44%) 18 (49%) 7 (58%) χ² = 1.85 (p = 0.76) 
History of substance abuse1         
  nicotine 14 (34%) 13 (35%) 7 (58%) Χ² = 2.50 (p = 0.29) 
  alcohol (units / week)2 15 15 6 F = 2.21 (p = 0.12) 
  cannabis 28 (68%) 25 (68%) 9 (75%) Χ² = 0.246 (p = 0.88) 
  hallucinogenics 10 (26%) 5 (14%) 1 (8%) Χ² = 0.242 (p = 0.30) 
  stimulants 14 (34%) 9 (24%) 4 (33%) Χ² = 0.82 (p = 0.66) 
  sedatives 4  (10%) 3 (11%) 2 (17%) Χ² = 0.74 (p = 0.69) 
1 
History of substance abuse refers to having ever used any of the substances, and differences were tested 
using Chi-squared tests. 
2
Alcohol abuse was measured in units per week, and differences were tested 







TBSS was performed according to standard methods in FSL, as described in Chapter 2. In the 
following statistical analyses, I first investigated whether there was any evidence for group-by-
genotype interactions using a general linear model in 'randomise' in FSL. In addition to the 
results of the F-test, I looked at the results of the separate T-tests for any differential genotype 
effects between the two groups, since from previous analyses it appeared that F-tests are 
surprisingly less sensitive than T-tests in FSL (also see my post regarding this problem on the 
FSL forum
2
). Secondly, three voxel-wise comparisons were performed on the TBSS skeletons in 
high risk and control groups separately: A-allele homozygotes vs. T-allele carriers, A-allele 
carriers vs. T-allele homozygotes and A-allele homozygotes vs. T-allele homozygotes. As 
mentioned in the introduction, there is evidence for sex-specific effects of DISC1. For this reason, 
I tested for sex-by-genotype interactions using an F-test as well as multiple T-tests. In an 
additional model I co-varied for sex to rule out any effects of rs821616 genotype could have 
been confounded by sex-differences. Finally, because unilateral brain differences may exist 
between left- and right-handed people, especially around the AF, additional analyses were 
performed on right-handed people only. Because genotype groups were well-matched on 
demographic variables known to impact on white matter integrity (Table 5.1), no further 
covariates were added to the statistical models. All reported results are significant at p < 0.05, 
corrected on the whole brain-level via TFCE (Smith & Nichols, 2009). 
 
5.2.3 Voxel-based analysis 
Any significant results in the TBSS analysis, were further explored using the more conventional 
voxel-based analysis of FA. Here, all individual FA maps were normalised to a standard MNI 
template using the FNIRT tool in FSL and smoothed with a FWHM kernel of 12mm, as it has the 
best trade-off between false-positives and sensitivity in diffusion data using parametric non-
stationary cluster inference (Hayasaka et al., 2004; Jones et al., 2005). To create an explicit 
white matter mask all FA maps were averaged, thresholded at FA > 0.15 and binarised. Voxel-
wise comparisons between DISC1 genotype groups were performed in SPM5 for each significant 







contrast in the TBSS analysis. To perform cluster-wise statistics, an initial threshold of p < 0.01 
(uncorrected) was applied to the statistical image. Subsequently, the whole-brain corrected 
significance of subthreshold clusters was assessed using the non-stationary cluster inference 
toolbox. This toolbox accounts for local variation in smoothness by using observed resel sizes in 
the calculation of cluster-wise statistics (Hayasaka et al., 2007). This way, an important source of 
false positive findings for cluster-wise testing is eliminated (Smith & Nichols, 2004; Moorhead 
et al. 2005). 
 
5.2.4 Tractography 
Probabilistic neighbourhood tractography was performed using TractoR , as described in Chapter 
2. Average FA, weighted according to the probability of the tract going through each voxel, was 
extracted from each tract of interest, namely the ATR, UF, CST and cingulum bundles bilaterally, 
and the genu and splenium of the corpus callosum. Average FA within each tract was analysed 
using mixed model regressions in SPSS 14, with hemisphere as within-subject variable and (risk) 
group and rs821616 genotype as between subject variables. For the genu and the splenium of the 
corpus callosum, I performed univariate ANOVAs with group and rs821616 genotype as 
independent variables. Although genotype groups were well-matched on demographic variables 
known to impact on white matter integrity, in a post-hoc analysis age, sex and IQ were added to 




In contrast to what happened in the NRG1 analysis in the previous chapter, the F-test was 
significant for the group-by-genotype interaction in a total of 18078 voxels (pFWE < 0.05), 
indicating the effect of genotype on FA is substantially different between the two groups. The T-
tests of the interaction effects were in agreement with this, with 2 significant (pFWE < 0.05) 





Significant group-by-genotype interactions led to analyses separate for the control and the high-
risk groups. In the control group, A-allele carriers at rs821616 had reduced FA compared to T-
homozygotes in three clusters (pFWE < 0.05; K = 33 929; K = 170; K = 46 voxels), together 
covering large parts of the TBSS skeleton (Figure 5.1, Table 5.2). Similarly, the contrast of A-
homozygotes versus T-homozygotes resulted in ten clusters (pFWE < 0.05; K = 21 259; K = 1061; 
K = 509; K= 381; K = 322; K = 272; K = 118; K = 14; K = 7; K = 6 voxels) widely distributed 
over the TBSS skeleton (Table 5.2). Part of these clusters, namely around the right AF, remained 
significant under a very stringent threshold of pFWE < 0.005 (Figure 5.2, Table 5.2). Contrasting 
A-homozygotes to the T-allele carriers resulted in four relatively smaller clusters (K = 285; K = 
77; K = 75; K = 50 voxels), mainly confined to the right AF and similar to the p < 0.005 results 
in the other two contrasts (Table 5.2). In the high risk group, no significant differences between 
genotype groups were observed. 
T-tests and F-tests revealed no significant genotype-by-sex interactions in the healthy control 
group on the whole-brain level (all pFWE > 0.33). This is also illustrated by Figure 5.3, showing 
that the effects of rs821616 on FA were similar in men and women in all significant clusters. 
Furthermore, results in the control group were very similar when left-handed individuals were 
excluded from the analysis. 
 
5.2.2 Voxel-based Analysis 
In the healthy control group, an ANOVA comparing all three rs821616 genotype groups resulted 
in one large cluster in the right hemisphere, strikingly following the curve of the AF (K = 14804, 
pFWE < 0.004; Table 2). An additional, smaller cluster was visible in the left temporo-occipital 
white matter, around the inferior longitudinal fasciculus (K = 4983, pFWE = 0.049; Table 5.2). In 
line with the TBSS results, post-hoc T-contrasts revealed that A-carriers had reduced FA 
compared to T-homozygotes in three clusters distributed over most of the cerebral white matter 
(Figure 5.4, Table 5.2), and AA homozygotes had reduced FA compared to TT homozygotes in 4 
similarly widespread clusters (Table 2). A striking overlap of the most significant voxels (pFWE < 
0.005) in this analysis with those from the TBSS analysis, which are mostly located around the 
right AF, is illustrated in Figure 5.2. In the high-risk group there were no significant effects of 
rs821616 and no supra-threshold trends (all corrected p-values > 0.4).                            
 
 
Figure 5.1. Reduced FA in carriers of the A allele at rs821616 in DISC1 in the control group, as demonstrate by TBSS (pFWE < 0.05). 







Figure 5.2. Comparison of most significant  (pFWE < 0.005) results between TBSS and voxel-based 




Table 5.2. Summary of voxel-based and TBSS results in the control group.
Method Contrast 
pFWE 
(RFT / TFCE) 
Location Size (voxels) 
Voxel-based F-test 0.004 Right AF 14804 
  F-test 0.049 Left TL and OL 4983 
  Acar < TT < 0.001 Distributed over RH and posterior LH 121059 
  Acar < TT 0.009 Left TL and OL, cerebellum 13415 
  Acar < TT 0.004 Left FL and PL 20577 
  AA < TT < 0.001 Distributed over RH 67846 
  AA < TT  0.015 Left cerebellum 11265 
  AA < TT 0.001 Left TL and OL 24007 
  AA < TT 0.008 Left FL and PL 16301 
TBSS – TFCE AA < Tcar 0.05 Right AF 258, 77, 75, 50 
  Acar < TT 0.05 Widely distributed 33929, 170, 46 
  Acar < TT 0.005 Right AF 3040 
  AA < TT 0.05 Widely distributed > 23000 
  AA < TT 0.005 Right AF 2082, 23, 4 
RFT = Random-field theory; TFCE = Threshold-free cluster enhancement; AF = arcuate fasciculus, TL = Temporal lobe; 






Figure 5.3. Average FA extracted from the significant clusters from each contrast in the TBSS 







Figure 5.4. Voxel-based analysis showing significant (pFWE < 0.05) FA reductions in carriers of the 




Figure 5.5 gives an overview of the effects of DISC1 genotype on FA averages within each tract, 
separated for group. For the AF, there was a group-by-genotype interaction (F = 3.829, p = 
0.023). Mixed model regressions separate for the control group and the high risk group revealed 
that rs821616 had a highly significant effect on the AF in the control group (F = 6.167, p = 
0.003), but not at all in those at high familial risk for BD (F = 0.097, p = 0.907). Individuals with 
the TT genotype had higher FA in both the left and the right AF (Figure 5.5). For the ATR, the 
effects of rs821616 on FA were more complex, with a three-way interaction between group, 
hemisphere and genotype (F = 4.795, p = 0.010). This is explained by a significant SNP-by-
hemisphere interaction in the high risk group (F = 7.309, p = 0.001), but not in the healthy 
control group (F = 0.417, p = 0.661). Specifically, in individuals at high genetic risk for BD, a 




but not on FA in the left ATR (F = 0.395, p = 0.675). Here, the AT genotype at rs821616 was 
associated with higher FA compared to both homozygous groups. For the UF, a trend for an 
interaction between rs821616 genotype and hemisphere was found (F = 2.558, p = 0.081). After 
splitting the analysis between the left and the right tracts, a moderately significant effect was 
found for the right UF across both groups (F = 3.147, p = 0.045), but not for the left (F = 0.345, 
p = 0.709). Post-hoc tests revealed that, again, the AT genotype was associated with the highest 
FA compared to both homozygous groups although looking at Figure 5.5 this seems to be mainly 
driven by the high risk group. 
Using a two-way ANOVA for the genu of the corpus callosum indicated that there was a trend 
for an effect of rs821616 genotype (F = 2.717, p = 0.069) across both control and high risk 
groups. This was found in the absence of a group-by-genotype interaction (F = 0.908, p = 0.405), 
although from the FA averages within genotype groups (Figure 5.5) it appears this effect is 
mostly driven by TT genotype in the control group and by the AT genotype in the high risk group. 
In this case, interaction effects may be difficult to detect because of the low T-allele frequency. 
Concerning the cingulum, there was a significant effect of rs821616 genotype on FA in the 
control group (F = 3.517, p = 0.034), but not in the high risk group (F = 0.142, p = 0.868), 
although the group-by-genotype interaction was not significant (F = 1.396, p = 0.251). Again, 
this paradoxical finding is probably due to the small TT-genotype group, which clearly plays a 
major role in the genotype effect, but at the same time may have too little influence to drive a 
group-by-genotype interaction. For the splenium and CST there were no indications for any 
effects of rs821616. 
 All tractography results were very similar, and most effects were more pronounced, when 
accounting for effects of sex, age and IQ in the statistical models. This was also the case when 
left-handed people were excluded from the analyses, apart from in the UF, where only a trend for 
an effect of genotype remained (F = 2.583, p = 0.079). The finding in the AF in the healthy 
controls comfortably survives a stringent - and overly conservative - Bonferroni correction of 
0.05 / [8(tracts) * 2(groups)] = 0.0031. The result in the right ATR in the high risk group also 










Table 5.3. Summary of effects of rs821616 genotype on FA, separated per tract. 
TRACT 
HC HR 
F p df η^2 F p df η^2 
genu 2.645 0.077 83 0.060 1.731 0.183 87 0.038 
splenium 0.301 0.741 83 0.008 0.677 0.511 87 0.015 
left AF 1.492 0.231 80 0.036 0.110 0.896 85 0.003 
right AF 6.634 0.002* 82 0.139 0.506 0.605 81 0.012 
left ATR 1.361 0.263 73 0.036 0.395 0.675 76 0.010 
right ATR 0.495 0.612 83 0.012 6.515 0.002* 85 0.133 
left CING 4.031 0.021* 81 0.091 0.205 0.815 84 0.005 
right CING 0.707 0.496 82 0.017 0.008 0.992 83 0.001 
left CST 0.238 0.789 81 0.006 0.093 0.912 87 0.002 
right CST 0.375 0.689 82 0.009 0.072 0.931 85 0.002 
left UF 1.097 0.334 71 0.030 0.057 0.944 65 0.002 
right UF 2.510 0.087 83 0.057 1.640 0.200 86 0.037 
Note that the main analyses were not performed on simple effects per unilateral tract, but as 
mixed regressions, across heispheres (and tracts). This table is included to provide meaningful 
effect sizes that allow for comparisons across studies, not for assessing the statistical signifi-
cance of the present findings per se. The values correspond to those illustrated in Figure 5.6.df 





In this chapter I present the first thorough investigation of the effects of genetic variation in 
DISC1 on white matter structure. I performed whole-brain analyses using TBSS as well as 
conventional voxel-based comparisons and I examined FA in specific connections of interest 
using probabilistic neighbourhood tractography. Overall, the results suggest that healthy people 
carrying the major allele (Serine) at the common, exonic SNP rs821616 have reduced white 
matter integrity compared to those homozygous for the minor (Cysteine) allele in many regions 
distributed over the cerebral white matter, and most robustly so in the right AF in which 
tractography, TBSS and voxel-based analyses all showed a highly significant genotype effect 





5.4.1. DISC1 and possible interactions with genetic background 
Interactions between familial risk-status and rs821616 genotype effects were common for many 
regions. In most cases they were driven by a larger genotype effect in the control group than in 
the high risk group. In agreement with this, two other studies also found pronounced effects of 
the Ser704Cys SNP on prefrontal activation (Prata et al., 2008) and grey matter density 
(Takahashi et al., 2009) in healthy individuals, but not in patients. This was also the case for the 
effects of NRG1 genotypes (Chapter 4), and in the case of DISC1 these may be similarly caused 
by floor effects and possibly sampling bias in the high risk group, or increased heterogeneity of 
the high risk sample. 
More speculatively, the present data also allow for an explanation on the biological level. The 
functional consequences of the Serine/Cysteine substitution are largely unknown, but it is 
possible that these are different against a vulnerable genetic background from functional 
consequences in the general population. A general pattern emerging from tractography analyses 
is that in the high-risk group, heterozygous individuals have the highest FA, whereas in the 
control group a more linear relationship exists between the number of T alleles and FA. It is 
possible that genetic variants within DISC1 or elsewhere interact with the functional 
consequences of the Serine/Cysteine substitution, making those processes that are beneficial to 
white matter integrity in the general population detrimental against a vulnerable genetic 
background. For example, Hashimoto et al. (2006) found that DISC1 resulting from the Serine 
variant (sDISC1) interacted more with the ERK pathway than DISC1 transcribed from the 
Cysteine variant. The ERK pathway is involved in neuronal development, plasticity and neuron 
and oligodendrocyte survival (Domercq et al., 2011), its activity is reduced in schizophrenic and 
bipolar patients (Yan et al., 2010), and it is a therapeutic target of mood stabilisers and 
antipsychotics (Einat et al., 2003; Engel et al., 2009; Xia et al., 2008). An increase in ERK-
related neuroprotective and growth stimulating processes should have a beneficial effect on 
white matter integrity in normal circumstances, but an atypical linkage disequilibrium pattern 
within the DISC1 region or the presence of risk-variants elsewhere in the genome could prevent 
an interaction with ERK or instigate the opposite effect. Of note, although the ERK pathway is to 
this date the only known functional consequence of the Serine/Cysteine substitution, it 
constitutes only one of the many DISC1 interactomes, and undoubtedly other pathways will be 




Serine/Cysteine in our two studied groups. For instance, the Serine/Cysteine SNP is located in 
the DISC1 region of which the protein products interact with various other key proteins in 
neuronal development and migration, and axon outgrowth (FEZ1, NUDEL1, LIS1). What is 
more, rs821616 genotype affects mRNA expression levels of each of these proteins in the post 
mortem brain of schizophrenia patients but not controls, while the expression of DISC1 itself 
was not affected in this study (Lipska et al., 2006). A third example of known DISC1 protein 
interactions is through DISC1’s function in the Wnt pathway via GSK3β (Brandon et al., 2009; 
Chubb et al., 2007; Mao et al., 2009), where the phosphorylation of DISC1 changes its role from 
stimulating progenitor cell proliferation to inhibiting it to initiate cell migration (Ishizuka et al., 
2011). These opposite roles of unphosphorylated versus phosphorylated DISC1 give way to 
many more possible explanations of how changes in DISC1 protein structure could have 
opposite effects on white matter development, depending on genetic and environmental 
backgrounds, as I presented here. Generally speaking, our data and the available literature can be 
integrated by imagining the DISC1 Serine/Cysteine SNP as one small player in a system of many 
genetic and environmental risk factors, which together disrupt the balance and functioning of 
protein cascades necessary for healthy brain structure. 
 
5.4.2. The risk-allele at DISC1 rs821616 
Despite the abundance of studies associating Ser704Cys with psychiatric illness and intermediate 
phenotypes, the literature disagrees substantially about which allele at rs821616 is the risk 
variant. Briefly, three studies found the major allele (Serine) was associated with an increased 
incidence of schizophrenia (Callicott et al., 2005; Chen et al., 2007; Zhang et al., 2005), whereas 
three studies found the minor the minor allele (Cysteine) to be over-transmitted in patients with 
schizophrenia (Song et al., 2007; Qu et al., 2007) or major depression (Lepagnol-Bestel et al., 
2010). Negative findings, mostly in smaller samples, also exist (Devon et al., 2001; Kim et al., 
2008; Rastogi et al., 2009; Saetre et al., 2008; Song et al., 2010; Zhang et al., 2006). With 
respect to intermediate phenotypes, most studies found the Serine variant related to decreased 
cognitive function and grey matter volumes, but opposite and negative findings also exist. 
Functional imaging findings are more difficult to categorise in terms of “risk” and “protective” 
allele effects, as discussed below. See Table 5.3 for a summary of intermediate phenotype studies 





Reasons for inconsistencies between studies could, as always, be sample heterogeneity and 
variations of methodology, but in this case an additional source could be the ambiguity inherent 
to A/T and C/G SNPs because of their strand symmetry (“A” on the positive strand is equivalent 
to “T” on the negative strand). More fundamentally, as others have also pointed out (e.g. Palo et 
al., 2007; Cannon et al., 2005; Thomson et al., 2005b), complex clinical phenotypes such as 
psychotic disorders are likely to be associated with multi-SNP haplotypes and even more distal 
multi-gene interactions making the effects of single polymorphisms, no matter how functionally 
relevant, difficult to detect. Intermediate phenotypes, on the other hand, are likely to be more 
sensitive to variation in specific, functionally relevant SNPs (Glahn, Thomson & Blangero, 
2007). 
 







Amino Acid intermediate phenotype (sub)population 
Callicott major Serine 
hippocampal grey matter and activa-
tion (task-dependent opposing effects) 
Caucasian 
Hashimoto minor Cysteine prefrontal FA, cing gyrus grey matter Asian 
Thomson major Serine cognitive impairment with ageing Male Caucasian 
  minor Cysteine cognitive impairment with ageing Female Caucasian 
DiGiorgio minor Cysteine 
hipp activation and functional connec-
tivity, hipp grey matter (trend) 
Caucasian 
Raznahan major Serine 
cortical development (thickness) in 
temp & front lobes 
Caucasian 
Takahashi major Serine frontal and temporal grey matter Healthy Asian 
  ns ns no clear effects on grey matter SCZ & SCZAFF Asian 
Palo major Serine visuospatial task, verbal fluency Caucasian 
Prata unsure unsure 
increased prefrontal activation during 
verbal fluency in Ser/Ser 
Healthy Caucasian 
  ns ns 
trend decreased prefrontal activation 
during verbal fluency in Ser/Ser 






But here, other problems can cause heterogeneity between studies. Firstly, reductions in 
volumetric or density measures of brain tissue do not always represent pathology. Dependent on 
the region or the measure, increases may also be indicative of pathology. This is especially true 
for functional MRI data in which increases in activation are commonly interpreted in terms of 
compensatory mechanisms or inefficiency. Grey matter measures derived from voxel-based 
morphometry methods can also be ambiguous for several reasons. Firstly, whilst gross measures 
derived from MRI on the voxel-level can give information about the tissue type, and estimate the 
amount of tissue both regionally and globally, they do not directly inform about the integrity of 
the microstructure or about the specific the cell-type or sub-cellular compartments within a voxel. 
Secondly, in tissue classification a trade-off can exist between white and grey matter, which can 
cause white matter pathology (or “reductions”) to manifest as “increases” in the adjacent grey 
matter. Thus, if DISC1 affects white matter integrity, as the above results suggest, different 
classification methods and grey matter measures could produce contradictory results. Finally, 
both association and intermediate phenotype studies commonly combine the heterozygous 
(Ser/Cys) individuals with individuals homozygous for the minor allele (Cys/Cys) into one group 
to increase statistical power. Whether or not this is justified depends on whether the data agrees 
with a dominant, recessive or linear model of genetic effects. For example, from the present 
study, it was the small homozygous (Cys/Cys) group that deviated most from the two other 
groups, at least amongst the healthy controls, meaning that in this case combining the minor 
allele carriers into one group would not give robust results. 
 
5.4.3.  Limitations 
A few limitations to the present analysis also need mentioning. Firsly, as with most studies, 
individuals homozygous for the minor allele were few: 10 in the control group and 12 in the high 
risk group. This made it difficult to detect genotype-group interactions without combining 
genotype groups, and impossible to investigate gene-gene interactions or multi-SNP haplotypes. 
Also, it was this smallest group in the control participants who deviated most from the two larger 
groups, and independent replications will need to exclude the possibility this was an incidental 
finding. On the other hand, that probability is by definition under 5% in each analysis, regionally 
below 0.5%, and even smaller for all results to agree across the different methods the way they 




As in previous chapters, other limitations are the lack of a patient group, the number of tracts 
excluded after tractography because of visible deviations from known anatomy, and the multiple 
testing associated with tractography. Previously the latter was alleviated by the initial 
significance of one large regression model, in which FA was predicted by tract, group and 
hemisphere. However, when it comes to dividing the groups according to genotypes, the 
addiction of a fourth variable incrementally reduces statistical power especially for detecting 
interaction effects (which are very likely in this context). The effect of rs821616 on FA remained 
significant for two tracts after conservative Bonferroni correction, namely the AF and the right 
ATR. The effect in the UF, on the other hand, did not survive such corrections. 
Finally, on a genetic level a few reservations on interpreting the findings should be kept in mind. 
Ser704Cys (rs821616) is one of the few non-synonymous, exonic SNPs in the DISC1 region 
(Devon et al., 2001) and to this date the only one for which a direct functional consequence has 
been identified, supporting the possibility that this SNP itself is responsible for the above 
findings rather than another SNP in close linkage disequilibrium. However, more research on 
molecular consequences of the serine/cysteine substitution is required to unequivocally confirm 
(or falsify) such a direct effect. Also, a genetic variant does not need to be non-synonymous and 
not even protein coding, for it to be directly or indirectly functional. Increasing evidence is 
emerging for the importance of non-coding SNPs in regulating expression or post-translational 
processes, including those transcribing micro-RNA and reversely transcribed, supporting a 
possible role for DISC2. Future research in molecular genetics will hopefully reveal more about 
the mechanisms by which Ser704Cys can have an effect on brain structure and function, 
including white matter integrity. 
Whether or not the Ser704Cys SNP is directly responsible for reductions in white matter 
integrity does not impede the main implications of the present study. From the above findings it 
can be concluded that white matter integrity is associated with genetic variation in a non-
synonymous DISC1 SNP. In individuals without a family history of psychiatric disorder this 
effect was evident in a large number of voxels widespread over the cerebral white matter, in 
which FA was increased in individuals homozygous for the minor cysteine allele. In unaffected 
relatives of bipolar patients, a different and somewhat less clear pattern emerged, with only 
tractography indicating increased FA in the genu of the corpus callosum, right ATR and right UF 




disorders and white matter integrity may be an endophenotype of psychotic disorders (Chapter 3), 
the present results provide a plausible mechanistic link between enhanced genetic risk through 





No association of the genome-wide supported ZNF804A SNP with 






In the first large genome-wide association study of schizophrenia the common SNP rs1344706 of 
the Zinc Finger Protein 804A gene (ZNF804A) was identified as the most significant genetic 
marker (p < 1.61 x 10
-7
)(O’Donovan et al., 2008). In the same study, combining schizophrenia 
and bipolar phenotypes showed an even higher association (p < 9.96 x 10
-9
), surpassing genome-
wide significance at p < 7.2 x 10
-8
 and suggesting the variant conveys susceptibility to the wider 
psychosis spectrum. Four independent replications have since confirmed its association to 
schizophrenia and BD (Riley et al., 2010; Steinberg et al., 2011; Zhang et al., 2011), including 
one independent replication of genome-wide significance, and a recent meta-analysis resulting in 
p-values up to 4.1 x 10
-13
 for the combined phenotype (Williams et al., 2011). 
 
6.1.1.  ZNF804A is associated with task-independent functional connectivity 
Despite this abundance of statistical evidence for the association of ZNF804A with psychosis, 
only modest effect sizes have been reported with odds ratios of around 1.10 (Donohoe et al., 
2010). Intermediate phenotypes such as functional connectivity and white matter integrity in the 
brain are therefore especially valuable because they are more proximal to the initial genetic 
effect than the clinical phenotype, and effect sizes are expected to be larger, thereby requiring 
smaller sample sizes to obtain a significant association (Glahn, Thompson & Blangero, 2007). 
An additional reason for studying intermediate phenotypes is that they enable one to examine 
directly which particular neuropathological processes or brain structures may be affected by a 
gene of interest. On the molecular level, all that is known about the ZNF804A function is that it 
is highly expressed in the brain and the presence of A-allele at rs1344704 creates a myelin 




comprehensive data on ZNF804A function comes from neuroimaging and neuropsychological 
data, collectively indicating that rs1344706 is associated with brain function. Esslinger et al. 
(2009) reported reduced functional connectivity between the left and right dorsolateral prefrontal 
cortices and increased fronto-temporal functional connectivity in carriers of the risk allele (A) 
during a working memory task. Importantly, in a subsequent study Esslinger et al. (2011) found 
that the reduced interhemispheric prefrontal connectivity was also apparent during a facial 
emotion processing and during rest, whereas the increased fronto-temporal connectivity 
appeared specific to working memory processes. This task-independent effect of ZNF804A 
genotype on interhemispheric prefrontal functional connectivity prompted the hypothesis that 
these effects may be mediated by effects on white matter integrity, especially in anterior 
interhemispheric connections. In line with this hypothesis, Lencz et al. (2010) found that 
individuals homozygous for the ZNF804A risk allele have reduced total white matter volumes 
(corrected for total intracranial volume) compared to carriers of the non-risk allele. However, 
total volumetric measures lack spatial specificity and are particularly susceptible to partial 
volume effects and segmentation difficulties, including ambiguity concerning a trade-off 
between white and grey matter volume. DTI is more suited to the study of white matter and FA is 
currently widely accepted to be the best measure for estimating white matter integrity in vivo. 
Surprisingly, using DTI tractography Voineskos et al. (2011) did not detect any effects of 
ZNF804A on FA in the UF, AF, CING or in the corpus callusum of 64 healthy individuals. 
Although they discuss the possibility of having missed any ZNF804A effects outside their tracts 
of interest, their chosen connections were the most relevant in the light of the functional 
connectivity differences found previously. 
Taken together, the myelin transcription factor binding site determined by the A-allele at 
rs1344706, the task-independent effects of ZNF804A on functional connectivity, the high 
heritability of FA and its association with genetic risk all converge in the hypothesis that 
structural connectivity is a mediator of rs1344706 effects on functional connectivity. This 
hypothesis is logically and scientifically appealing, and readily testable with FA as an objectively 
measurable approximation of white matter integrity. It is therefore not only surprising that 
Voineskos et al. (2011) failed to detect an association between ZNF804A and FA, but also that it 
is the only available report investigating the hypothesis since Esslinger et al. (2009) first 
suggested it, while positive associations of ZNF804A with cognitive performance and other brain 




2010; Walter et al., 2011; Hashimoto et al., 2010). This may be due to a lack of availability of 
combined genotype and DTI data, or to a publication bias disfavouring negative findings. In this 
chapter I therefore present a second, more detailed investigation of the possible effect of 
ZNF804A on FA using tract-based spatial statistics (TBSS) and tractography of the genu in the 
bipolar family sample. 
 
6.2 Methods 
All image acquisition, DTI pre-processing, TBSS and tractography procedures, and genotyping 
were performed as described in Chapter 2. 
 
6.2.1. Study Sample 
All participants were recruited as part of the Bipolar Family Study, as described in chapter 2. 
Both DTI data and blood samples were available from a total of 110 high-risk subjects and 83 
controls. Because some high-risk subjects were genetically related to each other, I randomly 
excluded one of each sibling pair to avoid statistical dependence in the sample, leaving 84 high-
risk and 83 controls in our final sample. Demographics and genotype results are summarised in 
Table 6.1. Allele frequencies at rs1344706 were similar to those previously reported (O’Donovan 
et al., 2008). For our principal analysis, subjects carrying the C-allele were combined into a C-
carrier group (CC + CA), as was done in previous studies of rs1344706 (Voineskos et al., 2011). 
Assuming the genetic effect is either linear or recessive, this increases statistical power when 
there is only a small group of C-homozygotes. Additional 3-group analyses were preformed to 
rule out any dominant or otherwise non-linear genotype effects. In the healthy control group age 
differed significantly between genotype groups. Therefore additional analyses were performed 
including age as a covariate for each statistical comparison below. There were no other 






Table 6.1 Demographic characteristics and genotype frequencies of the study samples. 
 Control Sample High Risk Sample 
rs1344706 AA AC + CC P AA AC + CC P 
N 31 39 + 13  37 36 + 11  
Age (years) 21.8  ± 2.3 20.7 ± 2.4 0.03* 21.4 ± 2.8 21.4 ± 2.8 0.94 
Sex (m / f) 14 / 17 23 / 29 0.93 17 / 20 22 / 25 0.94 
IQ 111.7 ± 11.9 112.2 ± 13.1 0.84 108.0 ± 13.9 104.6 ± 14.4 0.28 
  
6.2.2. Voxel-wise analysis 
FA values within the skeletons were compared between C-carriers and individuals homozygous 
for the A-allele within the control and high-risk groups separately, using voxel-wise non-
parametric T-tests calculated by FSL’s “randomise” tool. Statistics were corrected for multiple 
comparisons according to family-wise error (p < 0.05) using TFCE (Smith et al., 2009). For the 
control group, an additional analysis was performed with age included as a covariate. 
 
6.2.3 Small volume correction 
Because the two previous studies by Esslinger et al. (2009, 2011) showed ZNF804A was related 
to task-independent inter-hemispheric functional connectivity between the dorsolateral prefrontal 
cortices, a small volume correction (SVC) was applied to include only voxels within the skeleton 
and the body and genu of the corpus callusum. With an SVC only voxels in an a priori location 
are included in the analysis, thereby reducing the number of voxel-wise comparisons the 
statistics have to be corrected for and increasing the power to detect a significant effect. The 
SVC was created using the John Hopkins University white matter labels atlas in MNI space 
(Mori & van Zijl, 2011), thresholded to include only the genu and body of the corpus callosum, 
smoothed (FWHM 1.1 mm), binarised and multiplied with the skeleton mask to include only 
voxels that were in both the skeleton and the corpus callosum SVC (Figure 6.1A). Voxel-wise 





6.2.4 Region of interest analysis 
In addition to using the SVC as a region of interest (ROI), the average FA was extracted from 
this corpus callosum region and compared between genotype groups using independent sample 
T-tests. Because one extreme outlier (> 3 interquartile ranges from the median) was observed in 
the high-risk group, an additional analysis excluding this individual was performed. Additional 
ANOVAs with all three genotype groups were also performed to verify there were no dominant 
or otherwise non-linear genotype effects. 
 
Figure 6.1. Segmentation of corpus callosum regions of interest using TBSS and a white matter 








As described in chapter 2, probabilistic neighbourhood tractography was applied to trace the 
genu of the corpus callusum (Figure 6.1B). The weighted average FA values were compared 
between genotype groups using independent samples T-tests for the control group and high-risk 
group separately. Again, there was one extreme outlier in the high-risk group who was removed 
in an additional T-test. In addition, to confirm that any dominant or otherwise non-linear effects 
of ZNF804A on FA were not obscured by combining the CC and AC genotype groups, I 
performed analyses of variance (ANOVAs) of all three genotype groups on average FA within 
the genu. 
 
6.2.6 Power considerations 
Post-hoc power calculations are a controversial endeavour because they are often based on the 
observed effect size involving circular reasoning and a “power paradox” where higher (less 
significant) p-values correspond to both lower observed power and more evidence for the null-
hypothesis (Hoenig & Heisey, 2011). Therefore I took into account several power considerations, 
each no doubt with its own controversy or opponents, but altogether informative to interpret 
negative results. Power analysis of whole brain voxel-wise statistics are especially complicated, 
even without the consideration of TFCE. Sometimes a post-hoc power analyses is performed on 
the voxel that displayed the maximum effect. But this method assumes that if the alternative 
hypothesis is true, it concerns the effect in this particular voxel, ignoring the tens of thousands of 
other voxels, with smaller effect sizes, that could be considered for this role. If the alternative 
hypothesis were true in the population, it is extremely unlikely that it concerns the maximum 
voxel out of all possible voxels. Thus, such method ignores a multiple testing problem and by 
using the maximum effect size would result in a severe over-estimation of the likelihood of any 
true effect in the population. Methods have been developed for overcoming this problem in the 
more conventional MRI analysis techniques, but these are not widely accepted and none have 
been customised to TBSS and/or TFCE
3
. Considering this important limitation I have not 
performed a quantitative post-hoc power analysis for the voxel-wise TBSS analysis. However, 
                                                 
3




histograms of T-distributions across the TBSS skeleton were examined, which can give an 
indication of any supra-threshold trends. For example, in the case of a widely distributed signal 
(between-group difference) of small effect size, the whole histogram is shifted to the left or the 
right and in the case of focal signals of large effect size a small proportion of voxels stands out 
on one or both sides of the histogram. 
For the tractography and ROI analysis I examined statistical power in three ways: (1) confidence 
intervals around the observed group differences in relation to effects typically observed in 
similar studies and (2) the power of our study to detect such a typical effect size, and (3) the 
sample size that would be required to obtain a significant result given our own observed effect 
size. In each of these calculations I avoided using both our observed effect size and observed 
standard errors at the same time. I did not correct for multiple testing in these ROI analyses, 
because here it is more important to reduce type-II error than type-I error. However, it should be 
borne in mind that if our results were positive, a correction for multiple testing would be 
required and would increase p-values substantially. Therefore all calculations are under-




Allele frequencies of rs1344706 in our samples were similar to those reported previously (Table 
6.1) (O’Donovan et al., 2008). There were no significant deviations from Hardy-Weinberg 
equilibrium. No statistically significant differences (all P > 0.84) between rs1344706 genotype 
groups were found in age, sex, education, IQ for any of the samples, apart from an age difference 
in the Scottish control sample (Table 6.1). 
For TBSS, no significant differences in FA were found between the genotype groups in either the 
control or high-risk samples (all  pFWE > 0.38). No significant differences were found in the 
control sample after the model was adjusted for the effect of age (pFWE > 0.37). Histograms of 
raw T-statistics were normally distributed around zero, indicating that there were no trends for an 





Figure 6.2. No effect of ZNF804A genotype on average FA extracted from the corpus callosum 
ROI and genu. HC=healthy control group; HR=High risk group; “Ccar”=C-carriers. 
 
 
The application of a SVC over the body and genu of corpus callosum did not detect any FA 
differences between ZNF804A genotype groups using voxel-wise statistics with TFCE (p > 0.37). 
Average FA within the corpus callusum ROI did also not differ between genotype groups for the 
control group (T = -0.29, p = 0.78), nor for the high-risk group (T = -0.23, P = 0.82). 
Correspondingly, no significant genotype effects were found with tractography of the genu 
(controls: T = 0.58, P = 0.57; high-risks: T = 0.55, P = 0.58). Removal of the extreme outlier in 
the high-risk group did not change this negative result for either genu tractography (T = 0.02, p = 
0.99) or the corpus callosum ROI (T = 0.20, P = 0.84). As shown in Figure 6.3, there were no 
obvious trends in either direction for any of the comparisons. Finally, analyses of variance 
comparing all three genotype groups with respect to average FA within the genu and the corpus 
callosum ROI were all non-significant, with or without outlier (all F < 0.75, all P > 0.49), 
indicating that there were no non-linear or dominant effects of the risk-allele that may have been 





Out of the four corpus callosum analyses (tractography and ROI for each sample), only for the 
corpus callosum ROI in the healthy controls was the effect of ZNF804A genotype in the expected 
direction. For tractography of the genu, individuals homozygous for the A-allele had on average 
higher FA than C-carriers in both high risk and control groups, as was the case for the ROI 
analysis in the high risk group (Figure 6.2, Figure 6.3). Figure 6.3 shows that the maximum 
effect under the 95% confidence interval in either direction is just below 0.03 FA units. The 
maximum difference in the expected direction under the 95% confidence interval is 0.0216 FA 
units, for genu in the high risk group. In comparison, we previously reported a significant effect 
of NRG1 on FA the left ATR with an effect size of around 0.07 FA units (Sprooten et al., 2009) 
and voxel based FA studies have reported effects of BDNF (Chiang, Barysheva et al., 2011), 
ErbB4 (Konrad et al., 2009) and NRG1 (Winterer et al., 2008) genotypes of 0.05 to 0.11 FA units. 
In our analysis of DISC1 genotypes (Chapter 5) the mean FA difference within the cluster was 
0.04 FA units. These effects sizes are far outside the confidence intervals in the present study and 
we can therefore be fairly confident that ZNF804A has no such effect on FA in the corpus 
callusum. Conversely, Liu et al. (2010) reported effects of COMT haplotypes around 0.02 FA 
units, marginally within the scope of our widest confidence interval (genu in high-risk subjects). 
Correspondingly, with our own sample size and standard deviation, we had 83% power to detect 
an effect of 0.02 FA units in a two-tailed T-test (P < 0.05). Of note, the chosen effect size here, 
0.02 FA units, is the smaller of mean differences reported in similar studies, and corresponds to 
Cohen’s d ~ 0.5. 
Finally, using Statistical Analysis System (SAS Institute Inc.; http://www.sas.com) we calculated 
the required sample size to obtain significant results given the observed effect size. Considering 
the genu ROI in the healthy control group, individuals homozygous for the risk allele (AA) had 
on average 0.0019 lower FA than carriers of the C-allele, with standard deviations of SDAA = 
0.0255 and SDCcarriers= 0.0288. For 0.0019 to be significant with 80% power in a two-tailed T-test, 
given the observed variance and equal genotype group sizes, a sample size of N = 7324 would be 
required. I refrained from calculating required sample sizes for the other three analyses, because 






Figure 6.3. Mean differences in FA between genotype groups, and 95% confidence intervals. 




To date, rs1344706 locus of the ZNF804A gene is statistically the best supported SNP in 
association with schizophrenia and the wider psychosis phenotype (O’Donovan et al., 2008; 
Riley et al., 2010; Steinberg et al., 2011; Williams et al., 2011; Zhang et al., 2011), but the 
mechanisms by which it may affect susceptibility to psychosis are poorly understood. 
Associations of ZNF804A with cognitive (Esslinger et al., 2011; Walters et al., 2010; Hashimoto 
et al., 2010) and imaging (Voineskos et al., 2011; Esslinger et al., 2009, 2011; Lencz et al., 2010) 
phenotypes indicate that the gene modulates brain function and is involved in higher cognitive 
processes. So far most emphasis has been on the association of ZNF804A with functional 
connectivity, and more specifically with its effect on interhemispheric prefrontal connectivity 





Here, I present a thorough investigation of the relationship between genotype at rs1344706 of the 
ZNF804A gene and white matter integrity of the brain. Our study was motivated by a strong a 
priori hypothesis based on previous associations of this SNP with task-independent functional 
connectivity (Esslinger et al., 2009, 2011), the recent knowledge that the risk genotype at this 
SNP is responsible for creating a myelin transcription factor binding site (Riley et al., 2010; 
Voineskos et al., 2011), and FA as an established intermediate phenotype. Despite the use of 
various analyses methods and efforts to increase statistical power in two adequately sized 
samples, results were remarkably and consistently negative. 
Because proving equivalence statistically entails more than the absence of significant difference, 
we corroborate our negative findings with extensive examination of statistical power and any on-
significant trends. On closer examination of genotype group averages across methods and 
samples no trends were observed, with genotype group means differing seemingly at random in 
either direction, and histograms of T-statistics normally distributed around zero. More 
quantitative power calculations all seem to suggest the same: if there were any real effects at all 
they must be far smaller than what is typical for imaging genetics studies to have remained 
undetected in the present study. 
Although our DTI study should not be seen as an attempt to replicate the functional connectivity 
results of Esslinger and colleagues (2009, 2011), the question arises as to what can cause the 
discrepancy between the observed effects of ZNF804A on functional connectivity and its lack of 
effect on structural connectivity. With regard to methodology, possible explanations are 
population heterogeneity, lack of statistical power in the current study, and limitations of both 
DTI and fMRI-based functional connectivity. It is also possible that the reported effects of 
ZNF804A were sample specific, since most previous observations of ZNF804A effects on 
cognitive and imaging phenotypes were derived from the same or largely overlapping samples 
(Esslinger et al., 2009, 2011; Walter et al., 2011). In general, the interpretation of functional 
connectivity derived from fMRI is complicated by factors such as task-dependent effects and the 
possibility of activation in a third area modulating the correlation between two areas of interest, 
as well as by limitations of BOLD fMRI in the first place including regional differences in 
BOLD response and limited temporal and spatial resolution. Hence, the relationship of 
functional connectivity to underlying brain physiology or structural connectivity is not entirely 




voxel-wise FA analysis is obscured by co-registration difficulties and partial volume effects. 
Although we alleviated some of these limitations by applying several techniques such as TBSS 
and tractography in native space, DTI would fail to detect small-scale differences in structural 
integrity, especially when close at the synapse or near grey matter and away from large fibre 
bundles. But perhaps the most likely explanation is that ZNF804A has an effect on functional 
connectivity but not on white matter structure, for example by interacting with neurotransmitter 
synthesis or release, with receptor affinity or density, or because of common thalamic input. 
Grey matter integrity is also a possible mediator, for example through local dendrite density or 
growth or, as suggested by Voineskos et al. (2011), oligodendrocytes within the cortical neuropil. 
The latter is compatible with the A-allele in rs1344706 creating a myelin transcription factor 
binding site (Riley et al., 2010; Voineskos et al., 2011), and with the association with regional 
variation in cortical thickness (Voineskos et al., 2011). In vitro and animal research into the 
molecular and cellular functions of ZNF804A should investigate the plausibility of such 
mechanisms. 
In conclusion, we were unable to detect any effects of ZNF804A genotype on white matter 
integrity, in any of our three samples, using four different DTI analysis methods. Following this 
study the biological mechanisms of possible ZNF804A effects on functional connectivity remain 
unclear. After the paper by Voineskos and colleagues (2011) this is the second thorough 
investigation, using state-of-the-art imaging methods and larger sample sizes than most imaging 
studies, that has reported no association of ZNF804A with FA in the brains of healthy individuals. 
Therefore, any effects of variation in rs1344706 genotype on functional connectivity appear 







General conclusions and implications for the future 
 
 
I applied DTI to a unique sample of 150 young, unaffected relatives of patients with BD and 109 
well-matched healthy control participants to explore associations between genetic risk for BD 
and white matter structure in the human brain. First, the potential for white matter integrity as an 
endophenotype was considered by testing whether FA is reduced in unaffected relatives of 
patients with BD. After establishing this, I further investigated associations between FA and four 
of the best supported risk genes of BD - NRG1, ErbB4, DISC1 and ZNF804A - which were 
selected because of known functions that could impact on white matter development or plasticity. 
The use of white matter as an endophenotype in this context can provide clues to the 
mechanisms by which these genes confer risk to BD, and can aid in generating new, testable 
hypotheses for molecular, cellular and imaging research in psychiatry. In this last chapter I will 
summarise the key findings of this thesis along with its limitations, and suggest some ideas for 
future research using white matter integrity as an endophenotype. 
 
7.1. Summary of main findings 
In our sample, unaffected relatives of patients with BD had subtle but widespread FA reductions, 
as consistently demonstrated using traditional voxel-based methods, and the more innovative 
techniques of TBSS and probabilistic tractography. This was the only criterion of 
endophenotypes (Gottesman and Gould, 2003) that remained thus far unconfirmed for white 
matter integrity. In line with previous suggestive findings of either white matter volume 
(Kieseppä, et al., 2003), or density (McIntosh et al., 2005) reductions in unaffected relatives or,  
less directly, associations with scalar measures of genetic liability (Chaddock et al., 2009; 
McDonald, Bullmore et al., 2004;McIntosh et al., 2006), the present results support white matter 
integrity as an endophenotype for BD. Although we could not confirm more pronounced 
reductions in patients themselves, as would be required to exclude the possibility of confounding 
genetic or environmental factors unrelated to BD per se, there is ample evidence from post-




Chapter 1). This is also supported by an inverse correlation of cyclothymic temperament with FA 
in our own sample. 
Having confirmed the association of white matter to genetic risk for BD in general, it is natural 
to wonder whether part of this association could be attributed to one or more specific risk 
variants. I investigated potential contributions of known risk-variants in DISC1, ZNF804A, 
NRG1 and ErbB4, for their known roles in white matter development and plasticity and their 
previous associations with structural and/or functional connectivity in other samples. Modest 
associations were found between FA and genetic variation in NRG1 and to a lesser extent the 
gene encoding its receptor, ErbB4. Although the effects of NRG1 were most convincingly 
located in pre-hypothesised fronto-thalamic and fronto-limbic regions, confusingly, the variants 
most commonly associated with risk for psychiatric illness were associated with increased rather 
than reduced FA. Longitudinal studies in even larger samples are required to determine whether 
this could be a result of complex interactions with age or environmental factors, or is attributable 
variation elsewhere on the genome specific to our sub-population. A more striking result was a 
strong and robust association of FA with of variation in a non-synonymous DISC1 SNP, 
rs821616. This effect was highly significant in both voxel-based and TBSS analyses and was 
widespread over the cerebral white matter. The tractography results were overall less pronounced, 
and confined to selected tracts including the AF, genu and cingulum bundles for the control 
group and the ATR and UF in the high risk group. This slight discrepancy between methods may 
be caused by differences in statistical sensitivity, although we cannot exclude possible 
misregistration effects in the voxel-wise analyses. Overall, however, these findings are in line 
with known neurodevelopmental functions of DISC1 and encourage further research into its role 
in development and maintenance of white matter structure. Perhaps equally remarkable was the 
lack of association between ZNF804A and FA in any of the analysis conducted despite 
employing particularly lenient statistical thresholds and extra sensitive region-of-interest analysis. 
This lack of association was not attributable to insufficient statistical power and it strongly 
disagrees with a previously convincing, but untested, hypothesis which was based on a series of 
functional connectivity experiments (Esslinger et al., 2009; 2011). This negative finding has also 
been replicated in an independent German sample of healthy individuals (unpublished data). 
A few remarks are required on phenomena observed more or less consistently across several 




integrity diffusely over the brain. Although much research has focused on DISC1 expression in 
the hippocampus, DISC1 is abundantly expressed across the brain (Schurov et al., 2004) and has 
numerous interactomes through which it can impact on a wide range of brain functions. Among 
these, axon guidance and myelination are the most likely mediators of the effects observed here, 
and these are not regionally specific. Hence, disruption in DISC1 function may well have a 
similar effect on white matter across the cerebrum. A similar global effect is even more 
understandable for overall genetic risk, which reflects an increased likelihood of possessing any 
BD risk variants. The polygenic nature of BD means that the genomic location of this risk-
associated variation should vary widely and randomly between unrelated individuals, which can 
logically lead to an average diffuse effect extending over the whole brain. Secondly, the effects 
of DISC1, NRG1 and ErbB4 were more pronounced in the control group than in the high risk 
group. Although this may be counter-intuitive, as discussed in the respective chapters, it could 
reasonably be a result of a floor effect in the high risk group, increased heterogeneity in the high 
risk group, or an increased impact of environmental factors that may obscure the subtle effects of 
single genetic variants. It should, however, be mentioned that imaging artefacts, such as those 
related to motion, could also be more common in the high risk group, and that this may account 
for reduced sensitivity to detect gene-effects. 
 All of the results presented here require replications in independent samples. Some because they 
are very novel (i.e. the effects of DISC1), yet robust against all kinds of post-hoc validations, and 
others because the results bring about more questions than answers (e.g. NRG1/ErbB4). 
Nevertheless, all results are consistent with the idea that white matter integrity plays an 
important role in genetic risk for BD, as is not only demonstrated by a direct contrast between 
unaffected relatives and control participants, but also supported by the cumulatively convincing 
evidence for associations with DISC1, NRG1 and ErbB4. 
 
7.2. Methodological remarks and limitations 
With regard to methodology, a first noteworthy observation was the good correspondence 
between the voxel-based, TBSS and tractography results. Overall, the voxel-based results were 
somewhat less significant than the TBSS results, presumably reflecting the superior registration 




voxels within the skeleton. It is slightly surprising that tractography results were also less 
pronounced than TBSS in most cases, despite the strict multiple testing corrections required for 
voxel-wise comparisons, and the assumed registration-related error. However, as noted 
elsewhere, TFCE could also increase sensitivity if the signal is of small effect but of large extent 
(i.e. spatially consistent). Although the correspondence between the methods greatly increases 
confidence in the current findings, it should be kept in mind that all analyses were based on the 
same dependent variable: FA. As reviewed in Chapter 2, DTI and derived measures such as FA 
are only an approximation of white matter structure and the scale at which they are measured 
limits biological interpretations of their variation. FA can be regarded a sensitive and reliable, 
albeit non-specific, measure of white matter integrity, but post-mortem animal studies are 
necessary to confirm the relatively crude imaging results and to distinguish properly between the 
various sources of variation in FA (i.e. myelination, axonal damage) and their causes (i.e. 
developmental or plasticity-related, and the role of oligodendrocytes). 
The narrow age range in our sample is a strength since it means the sample is relatively uniform, 
as well as a limitation, as discussed in previous chapters. The age of our subjects could have 
influenced the results for two clinical reasons. On the one hand, a small proportion of the 
unaffected relatives is likely to develop BD after the assessment, although they are unlikely to 
have driven the present results given the absence of outliers and their small proportion. On the 
other hand, a few individuals were excluded because they were diagnosed with major depression 
or BD, but given their small number this is unlikely have skewed our sample to the extent that 
the remaining subjects have significantly more protective genetic variants. In addition, 
considering their known roles in brain development, the investigated genes are likely to interact 
with age, something that, because of the narrow age range, could not be properly addressed in 
the current sample. Follow-up assessments of our participants have recently been completed and 
further analyses of this data should clarify some of these issues. In addition, other studies have 
investigated particularly young children or adolescents (Versace et al., 2010; Frazier et al. 2007) 
or older participants (Chaddock et al., 2009), and integrating our results with those, it seems that 
genetic risk (as in familial risk) clearly interacts with white matter development, but mostly only 






7.3. Implications for the future 
In the early 20
th
 century Carl Wernicke first suggested that disrupted connectivity may lie at the 
core of psychotic symptoms. More recently, the most comprehensive theories of psychosis, and 
in particular hallucinations, as well as affective disorders are based on similar ideas (Friston, 
1999; Frsiton & Frith, 1995; Phillips et al., 2008; Strakowski et al., 2005). Despite this, in 
scientific research white matter has always been only of secondary interest to grey matter, as can 
be clearly deduced from systematic reviews and from a simple PubMed search. The recent 
availability of DTI has caused a surge in imaging studies focusing on white matter, and during 
this short period evidence for white matter involvement in psychosis has mounted to compelling 
heights. However, as mentioned, DTI on its own is never enough to confirm and fully understand 
subtle white matter pathology, and there remains a shortage of histological, animal, cellular and 
molecular studies focussing on white matter. For example, as mentioned in Chapter 1, all post-
mortem studies of BD have only looked at cortical regions, even those that addressed myelin or 
glia pathology did not stain deep white matter. This lack of research in white matter is not only 
apparent in pathology, but also in basic neuroscience. For example, the mechanisms of synaptic 
plasticity in grey matter have been known since the 1960s (Lømo, 2003), but it has only recently 
emerged that similar activity-dependent structural changes can occur in white matter (Fields et al. 
2008; Demerens et al. 1996). Thus, while it is slowly becoming clear that white matter is far 
more complex than just a set of static “wires” that passively conduct nerve impulses, a lot 
remains to be discovered before we can make better informed hypotheses about the mechanisms 
that cause its pathology. 
Following from the present findings, white matter is arguably the best supported biological 
endophenotype for BD. Although it is presumably rather unspecific to BD per se, it could be an 
extremely helpful phenotype in animal studies, which do not have many superior alternatives 
when it comes to psychiatric research. Furthermore, as an endophenotype white matter integrity 
can be assumed to be somewhere midway between genetics and clinical phenotype, and can 
therefore be useful as a basis for initial hypotheses to test the biological function of novel genetic 
risk-variants. 
As mentioned above, neurodevelopmental processes are assumed to be involved in BD, as 
compatible with the functions of many risk-genes. Longitudinal studies, incorporating wider age 




by Versace et al. (2010). In particular, the expression patterns and functions of DISC1 vary 
across developmental stages and for example it remains to be elucidated whether there are any 
critical time-windows for DISC1 disruption to affect white matter structure, or whether DISC1 
influences myelination and/or axonal integrity in the mature brain, in addition to its known role 
in the developing brain. 
Having established the potential of white matter integrity as an endophenotype, probably the 
most obvious next step is to use this quality in the discovery of new genetic variation and in the 
confirmation and functional understanding of known variants. In addition to the present efforts to 
increase understanding of DISC1, NRG1, ErbB4 and ZNF804A function, we recently started 
using average FA extracted from the TBSS skeleton as a phenotype in a GWAS in our own 
dataset. However preliminary given our small dataset, the results sensibly confirm the over-
representation of relevant gene-ontology categories and nominal effects of known psychosis-risk 
genes (unpublished data), which is more than what has been achieved in many case-control 
GWAS in much larger samples. Nevertheless, no SNP or gene reached genome-wide significance 
and larger datasets are required to conduct an adequately powered white matter GWAS. 
 
7.4. General conclusion 
In our sample, subtle but widespread white matter integrity reductions were present in 150 young, 
unaffected relatives of patients with BD compared to 109 well-matched healthy control 
participants, in support of white matter integrity as an endophenotype of BD. This is also 
supported and further extended by a striking association of white matter integrity with a non-
synonymous DISC1 SNP and more modest associations with genetic variation in NRG1 and 
ErbB4. Together, the results provide compelling evidence for white matter structure as an 
endophenotype for BD, and encourage the use of white matter integrity as an endophenotype in 
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